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ABSTRACT
Yury J. Sigal: Lipid Phosphatases and Related Proteins: From Regulation of Phospholipid
Metabolism to Filopodia Formation
(Under the direction of Vytas A. Bankaitis)
Phospholipids and sphingolipids play critical roles in signal transduction, intracellular
membrane trafficking, and control of cell growth and survival. We discuss recent progress in
the identification and characterization of a family of integral membrane proteins that play
central roles in bioactive lipid metabolism and signaling. These five groups of homologous
proteins, which are collectively termed Lipid Phosphatases/Phosphotransferases (LPTs), are
characterized by a core domain containing six transmembrane spanning -helices connected
by extramembrane loops, two of which interact to form the catalytic site. LPT family
members are localized to all major membrane compartments of the cell. The transmembrane
topology of these proteins places their active site facing the lumen of endomembrane
compartments or the extracellular face of the plasma membrane.
Lipid phosphate phosphatases (LPPs) are the best characterized members of the LPT
family. By hydrolyzing lysophosphatidic acid (LPA), sphingosine 1-phosphate (S1P) and
structurally related substrates, LPPs control intracellular lipid metabolism and regulate cell
surface receptor-mediated signaling of S1P and LPA by inactivating these lipids at the
plasma membrane. Similarly, other LPT family members, such as sphingomyelin synthases
(SMS) and sphingosine phosphate phosphatases (SPP), have been reported to mediate intra-
and extra- cellular lipid metabolism with implications in regulation of cell survival and
iii
apoptosis. The remaining members of the LPT family, lipid phosphatase related
proteins/plasticity related genes (LPR/PRG) and type 2 candidate sphingomyelin synthases
(CSS2) are presently much less well studied. These two groups include proteins that lack
critical amino acids within the catalytic site and could therefore not use the conserved LPT
reaction mechanism to catalyze lipid phosphatase or phosphotransferase reactions.
Herein we describe procedures used to analyze the expression and enzymatic
activities of LPPs in mammalian and insect cells. Furthermore, we demonstrate that LPR1, a
member of the LPR/PRG proteins, despite its enzymatic inactivity, regulates dynamic cell
surface protrusions that are identified as filopodia. Analyses of the molecular composition
and the mechanistic determinants of these structures reveal that LPR1 regulates filopodia
formation in a cdc42 and arp2/3 independent manner. These studies demonstrate a link
between the ability of LPTs to interact with phospholipids and influence aspects of cell
morphology.
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CHAPTER 1
INTEGRAL MEMBRANE LIPID PHOSPHATASES/
PHOSPHOTRANSFERASES: COMMON STRUCTURE
AND DIVERSE FUNCTIONS
Reproduced with permission from: Sigal, Y. J., McDermott, M. I. and Morris, A. J. (2005)
Biochem J 387, 281-93. Integral membrane lipid phosphatases/phosphotransferases:
common structure and diverse functions. © Biochemical Society.
21. INTRODUCTION
The realization that membrane lipids play critical roles in many aspects of cell
regulation is one of the most important advances in biomedical research in the past 30 years.
The identification of many of the enzymes responsible for catalyzing critical reactions in
pathways of bioactive lipid metabolism has often lagged behind what continues to be steady
and impressive progress in the definition of reactions and pathways responsible for the
synthesis and inactivation of bioactive lipids and their metabolites. This is largely because
the proteins responsible are often tightly associated with cell membranes making them
difficult to isolate and work with biochemically. Activity of these enzymes is
characteristically dependent on the physical form of their substrates which impedes the
design and interpretation of in vitro assays to detect and quantitate them. This is a particular
issue with assays using detergent solubilized substrates which are a necessity when working
with enzymes that require membrane solubilization. The identification of several important
families of these lipid metabolizing enzymes has therefore most often resulted from a
combination of hard work, serendipity and ingenuity rather than the “traditional” approach of
protein sequencing, cDNA cloning and, more recently, bioinformatics. The progress
discussed in this article began in the 1960s with the identification of membrane-associated
phosphatidic acid (PA) phosphatase activities (Coleman and Huebscher, 1962; Hokin and
Hokin, 1961), and has culminated in the recent recognition that the enzymes responsible for
this activity, which are collectively termed lipid phosphate phosphatases (LPPs) (Brindley
and Waggoner, 1998; Kai et al., 1996; Kai et al., 1997; Roberts et al., 1998), belong to a
larger family of proteins that includes the sphingosine phosphate phosphatases (SPPs)
(Mandala, 2001; Mandala et al., 2000), the long-sought animal sphingomyelin synthases
3(SMS) (Huitema et al., 2004) as well as two groups of proteins, the lipid phosphatase related
proteins/plasticity related genes (LPR/PRG) (Brauer et al., 2003; Brindley, 2004; McDermott
et al., 2004; Savaskan et al., 2004; Sigal et al., 2007) and type two candidate sphingomyelin
synthases (CSS2) (Huitema et al., 2004) with less well characterized enzymatic activities and
functions.
2. IDENTIFICATION OF THE LIPID PHOSPHATASE/PHOSPHOTRANSFERASE
FAMILY
Although the important role of LPPs in glycerophospholipid metabolism and
signaling had been long recognized and their activities characterized biochemically in some
detail (Waggoner et al., 1996; Waggoner et al., 1995), difficulties in purifying the proteins
responsible meant that these enzymes were not characterized at a molecular level until 1996
(Kai et al., 1996; Kai et al., 1997). Recognition of homologies between two S. cerevisiae
open reading frames and a bacterial integral membrane lipid phosphatase that
dephosphorylates phosphatidylglycerol phosphate (Stukey and Carman, 1997), coupled with
success in purification and sequencing of a mammalian LPP, revealed the existence of a
family of homologous enzymes in yeast and mammals with broad specificity for lipid
phosphates including LPA, S1P, phosphatidic acid (PA), ceramide 1 phosphate (C1P) and
diacylglycerol pyrophosphate (DGPP) (Hooks et al., 1998; Jasinska et al., 1999; Kai et al.,
1996; Kai et al., 1997; Roberts et al., 1998). A genetic screen in yeast subsequently
identified two further homologous proteins that were selective S1P phosphatases (Mao et al.,
1997), and mammalian homologs of these enzymes were identified by both a
complementation cloning approach and genome-wide sequence analysis (Johnson et al.,
42003; Mandala et al., 2000; Ogawa et al., 2003). While progress in understanding the
functions of these mammalian LPP and SPP enzymes has continued steadily, exciting
advances in the past several years have led to the identification of three further groups of
proteins that share the overall transmembrane topology of LPPs and SPPs but are
characterized by variations in the core catalytic domain sequence motifs that define this
family of proteins, and in the length and primary sequence of the N- and C-terminal portions
of the proteins that flank the catalytic core. In this review, we collectively refer to this multi
gene family of integral membrane enzymes as lipid phosphatases/phosphotransferases
(LPTs). One group of these newly identified proteins, the sphingomyelin synthases (SMS),
are mammalian homologs of the S. cerevisiae Aur1 gene product that catalyze the reversible
interconversion of phosphatidylcholine (PC) and ceramide (Cer) with diacylglycerol (DG)
and sphingomyelin (SM) (Huitema et al., 2004). The other two groups of LPT family
proteins are presently much less well described. The first of these have been termed lipid
phosphatase related proteins or plasticity related genes (LPR/PRG). Two of the four
LPR/PRG proteins have a novel and unexpected role in regulation of cellular morphology
(Brauer et al., 2003; McDermott et al., 2004; Savaskan et al., 2004; Sigal et al., 2007). The
final homology group of LPT family proteins, provisionally termed type 2 candidate
sphingomyelin synthases (CSS2) have presently uncharacterized enzymatic activities and
functions (Huitema et al., 2004). Figure 1.1 shows a dendrogram illustrating the overall
sequence similarity relationships between the five classes LPT proteins noting a more distant
relationship of these proteins to glucose 6-phosphatase (G6P), another integral membrane
phosphatase enzyme with a similar transmembrane topology and, as discussed in more detail
below, partial active site homology with the LPT family proteins. Although the tissue
5Figure 1.1 Primary Sequence Relationships Between Lipid
Phosphatase/Phosphotransferase Family Members.
A dendrogram representing primary sequence homology relationships between members of
the LPT family is shown. The dendrogram was generated from a TCoffee alignment of the
relevant sequences using Tree View (Page, 1996).
6distribution of RNA and protein has been reported for some LPT family members (Brauer et
al., 2003; Kai et al., 1996; Kai et al., 1997; Ogawa et al., 2003; Savaskan et al., 2004; Sciorra
and Morris, 1999), expression of these genes in mammalian cells and tissues has not yet been
examined in a comprehensive and systematic manner. Analysis of the tissue distribution and
relative abundance of expressed sequence tag (EST) sequences provides a useful and
quantitative way to evaluate gene expression patterns. Table 1.1 summarizes extensive
information about the expression pattern of all members of the LPT family in adult human
tissues complied from EST abundance data available on line
http://www.ncbi.nlm.nih.gov/UniGene/. Expression patterns of the individual genes are
discussed in more detail in the corresponding sections of the article.
3. PRIMARY SEQUENCE AND TRANSMEMBRANE ORIENTATION
Figure 1.2 shows a schematic diagram of the proposed transmembrane orientation,
topology and structural organization of members of the LPT family. These are all single
polypeptide enzymes. Hydropathy analysis identifies six regions of hydrophobic sequence
that could form transmembrane -helices which are numbered 1-6. These helices are linked
by extra membrane loops numbered i-v. The lengths of these loops vary between family
members. This structurally conserved core domain is flanked by N- and C-terminal
extensions. These are also of varying lengths, and differences in the size and sequence
composition of the N- and C-termini are defining features of particular members of the five
classes of LPT proteins. This proposed transmembrane topology has only been confirmed
experimentally for LPP3 (Barila et al., 1996). A protease susceptibility study of the SMS
enzymes indicates a cytoplasmic orientation of the C-terminus, which is also consistent with
7Table 1.1 Expression of LPT Family Proteins in Adult Human Tissues. Expression profiles for the indicated genes were compiled from data available at
http://www.ncbi.nlm.nih.gov/UniGene/. The abundance of expressed sequence tag transcripts corresponding to each gene is expressed as transcripts per million.
EST Abundance (Transcripts per Million)
LPP1 LPP2 LPP3 SPP1 SPP2 LPR1/
PRG3
LPR2/
PRG4
LPR3/
PRG1
LPR4/
PRG2
SMS1 SMS2 CSS2 CSS2
Bladder 191 0 47 191 47 0 0 0 0 0 0 0 47
Bone 35 17 143 0 0 0 53 0 0 0 17 17 35
Bone Marrow 27 0 136 54 0 0 0 0 27 109 27 0 27
Brain 107 30 166 35 19 48 181 124 17 48 13 45 24
Cervix 72 48 24 0 0 0 24 0 0 24 0 0 0
Colon 64 347 58 0 88 0 35 0 11 17 5 0 17
Eye 80 43 222 0 12 18 92 18 30 55 0 37 6
Heart 161 0 287 0 0 0 53 0 0 71 35 17 53
Kidney 172 44 202 37 112 29 7 0 0 44 14 7 37
Larynx 41 0 292 0 0 0 0 0 0 251 0 0 0
Liver 22 7 197 38 7 0 0 0 7 68 15 0 76
Lung 67 56 106 14 81 7 24 10 3 35 38 3 10
Lymph Node 39 0 724 31 7 0 0 0 23 85 0 0 15
Mammary Gland 132 24 490 0 33 0 41 0 0 57 33 0 8
Muscle 119 0 82 9 18 0 0 0 0 36 73 18 9
Ovary 63 116 21 0 31 10 116 0 10 31 10 21 21
Pancreas 74 211 161 0 12 0 87 0 12 12 37 0 0
Peripheral N.S. 318 0 238 0 39 0 159 0 0 119 0 39 0
Placenta 108 4 535 77 4 0 21 8 0 82 38 0 30
Prostate 483 38 576 7 15 0 42 0 12 0 31 23
Skin 30 12 6 24 24 0 0 0 0 0 0 0 6
Soft Tissue 102 0 153 0 0 51 0 0 0 0 102 0 0
Spleen 0 0 0 0 0 0 0 0 0 120 0 0 0
Stomach 77 58 48 48 77 0 48 0 0 29 67 0 58
Tongue 36 0 36 0 145 0 0 72 0 109 0 0 0
Testis 60 7 68 7 15 7 7 15 15 83 30 0 30
Thymus 0 0 0 222 0 0 0 0 0 0 0 0 666
Uterus 196 156 214 0 17 0 11 0 5 57 34 0 17
Vascular 154 0 656 0 38 0 0 0 0 308 38 0 0
Whole Blood 105 0 39 13 13 0 52 0 26 66 0 0 0
8this predicted topology (Huitema et al., 2004). The yeast and mammalian SPPs and two of
the LPR/PRG proteins have much longer C-termini than all other LPT family members.
While the C-termini of the LPR/PRG proteins are highly hydrophilic and unlikely to form
additional membrane spans, the C-termini of the SPPs contain additional hydrophobic
sequences that, by hydropathy analysis, are predicted to form two additional membrane
spanning -helices denoted 7 and 8 in figure 1.2 (Johnson et al., 2003; Mandala et al., 2000;
Mao et al., 1997). A recent examination of the protease susceptibility of a series of epitope
tagged variants of one of the yeast SPP enzymes demonstrates the presence of these
additional membrane helices (Kihara et al., 2003) and it will be interesting to determine if
this topology is conserved in the mammalian SPPs. Two other lines of evidence support the
proposed transmembrane topology of the common core domain of these enzymes. Firstly,
some but not all family members contain a functional glycosylation sequence in loop iii
implying that this region of the proteins has access to the lumen of the endoplasmic reticulum
and Golgi apparatus as it traverses the secretory pathway (Barila et al., 1996; Kai et al., 1996;
Sciorra and Morris, 1999). Secondly, as discussed in detail in the following section, the
catalytic site of the enzymes is formed from three sequence motifs that are located in loops
iii and v and transmembrane sequences that immediately precede these loop regions
(Hemrika et al., 1997; Neuwald, 1997; Stukey and Carman, 1997). The fact that these
regions must be adjacent to each other to interact in order to form the catalytic site of the
enzymes also requires that transmembrane helices 4-6 are oriented as shown in Figure 1.2.
A detailed study of the transmembrane topology and active site organization of the integral
membrane glucose 6-phosphatase is also consistent with a functional interaction between
catalytic residues located in loops iii and v (Pan et al., 1998).
9Figure 1.2 Structural Organization of Lipid Phosphatase/Phosphotransferase Family
Members. A. schematic diagram illustrating the transmembrane topology of members of the
LPT family. B. Schematic diagram illustrating the structural organization of members of the
LPT family.
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4. ACTIVE SITE STRUCTURE AND CATALYTIC MECHANISM
Shortly following the identification of the mammalian LPP and yeast DPP
(diacylglycerolpyrophosphate phosphatase) genes, three groups of workers noted that LPPs
belong to a phosphatase superfamily that is defined by a shared motif comprising three
separate sequences denoted C1, C2 and C3 located in the third and fifth extramembrane
loops and proximal transmembrane sequences (Hemrika et al., 1997; Neuwald, 1997; Stukey
and Carman, 1997). This motif is conserved in the S. cerevisiae DPPs, E. coli
phosphatidylglycerol phosphatase (PgpB), mammalian G6Ps and SPPs. Figure 1.3 shows
alignments of the relevant catalytic domain sequences of all known mammalian members of
the lipid phosphatase/phosphotransferase family. A critical insight independently noted by
these investigators was that this phosphatase motif is also found in the active site of fungal
oxyanion-dependent haloperoxidases. These enzymes share a common active site
configuration and reaction chemistry that has been best studied for the vanadium-dependent
chloroperoxidase (CPO) from the fungus Curvularia inaequalis. This enzyme uses hydrogen
peroxide to catalyze the oxidation of halides to their corresponding hypohalous acids. Its
three dimensional structure has been solved at atomic scale resolution (Hemrika et al., 1997).
The active site of CPO is formed from four -helices linked, on one face, by short
polypeptides containing the phosphatase consensus motif sequences. Prompted by the
observation that the active site of CPO is homologous to that of the integral membrane
phosphatases, CPO was also shown to be a broad specificity phosphatase with activity
against para-nitrophenol phosphate and several other synthetic substrates (Renirie et al.,
2000b). High resolution structural information, coupled with mutagenesis and measurements
of enzymatic activity as well as spectroscopic studies of oxyanion binding to CPO isoforms
11
Figure 1.3 Catalytic Domain Sequence Conservation Among Lipid Phosphate
Phosphatase/Phosphotransferase Family Members.
Alignment of catalytic domain sequences of members of the LPT family with cognate
sequences from a fungal haloperoxidase (CPO), bacterial phosphatidylglycerol phosphatase
(PgpB), yeast diacylglycerol pyrophosphatase (DPP1) and human glucose 6-phosphatase
(G6P) are shown.
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from several fungi indicate that the trigonal bipyrimidal vanadate cofactor required for the
halide oxidation reaction interacts with the enzyme in the same manner as the transition state
phosphate intermediate of the phosphatase reaction. The C3 histidine and aspartic acid
residues operate as a charge relay system in which the histidine residues acts as a nucleophile
driving formation of a phosphohistidine intermediate. The C2 histidine facilitates phosphate
bond cleavage and participates in the second step of the reaction in which the
phosphohistidine intermediate is hydrolyzed freeing the active site for another round of
catalysis. The invariant lysine, arginine, serine and glycine residues of the C1, C2 and C3
regions donate hydrogen bonds to the phosphate oxygens and stabilize the transition state of
the reaction (Figure 1.4) (Hemrika et al., 1997; Macedo-Ribeiro et al., 1999; Renirie et al.,
2000a; Renirie et al., 2000b). Although no structures are presently available for any of the
integral membrane phosphatase/phosphotransferases, this detailed information about the
catalytic mechanism of CPO provides an experimentally validated framework for
understanding how the LPP and SPP enzymes catalyze hydrolysis of their substrates
(Furneisen and Carman, 2000; Toke et al., 1999; Zhang et al., 2000b) and indicates how the
SMS enzymes have likely adapted this reaction chemistry to perform a phosphotransferase
reaction (Huitema et al., 2004). Finally, the incomplete conservation of the phosphatase
active site in the LPR/PRG proteins and in one of the CSS2 proteins implies that they could
not catalyze a phosphatase reaction using this mechanism (Brauer et al., 2003; Huitema et al.,
2004; McDermott et al., 2004; Savaskan et al., 2004; Sigal et al., 2007).
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Figure 1.4 Lipid Phosphatase/Phosphotransferase Reaction Mechanism.
A schematic representation of the catalytic mechanism LPT family members highlighting
functions for the conserved residues of the C1, C2 and C3 sequences of conserved catalytic
motif in the reaction chemistry.
5. LIPID PHOSPHATE PHOSPHATASES
Structural organization and enzymology- LPPs are the prototypic members of the
lipid phosphatase/phosphotransferase family. The three mammalian enzymes, LPPs1-3,
catalyze divalent cation-independent hydrolysis of lipid phosphomonoesters (Kai et al., 1996;
Kai et al., 1997; Roberts et al., 1998) and can also perform complete dephosphorylation of
diacylglycerolpyrophosphate, indicating that they have phosphodiesterase activity against a
pyrophosphate bond (Dillon et al., 1997). However they will not cleave the phosphodiester
bond of glycerophospholipids. Although there are modest differences in Vmax and interfacial
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Km values when analyzed using a mixed micellar assay system, LPPs hydrolyze a range of
lipid phosphomonoesters that include LPA, PA, S1P and C1P with broadly similar activities
(Roberts et al., 1998; Waggoner et al., 1996). They do not hydrolyze the phosphomonoester
groups of the phosphoinositides PtdIns(4)P and PtdIns(4,5)P2, and will not hydrolyze soluble
substrates such as glycerol 3-phosphate. Although LPPs can hydrolyze substrates in complex
with BSA (Roberts et al., 1998) and are clearly enzymatically active in biological membranes
and when reconstituted into artificial lipid bilayers (Roberts and Morris, 2000), they are
markedly more active against substrates dispersed in non-ionic detergents, particularly Triton
X-100 (Roberts et al., 1998; Waggoner et al., 1996). The invariant amino acids of the C1, C2
and C3 phosphatase motif are completely conserved in these mammalian LPP enzymes and
mutagenesis studies of S. cerevisiae DPP1, LPP1 and LPP3 indicate that their catalytic
mechanism is identical to that demonstrated for CPO (Escalante-Alcalde et al., 2003; Toke et
al., 1999; Zhang et al., 2000b). The issue of what makes these enzymes broadly specific for
lipid phosphate substrates in comparison to the SPP and SMS enzymes which are highly
selective (see below) is presently unresolved. As discussed below, SPPs also contain a
completely conserved C1- C2- C3 phosphatase motif with a minor substitution in the C2
sequence (Ser-Thr-His instead of Ser-Gly-His) yet these enzymes appear to be absolutely
selective for S1P (Le Stunff et al., 2002c). The possibility that this simple substitution in the
C2 sequence accounts for this dramatic difference in substrate specificity is an interesting but
as yet untested idea.
Expression, localization and functions- LPP1 and LPP3 are widely expressed in
human tissues while levels of LPP2 transcripts are somewhat lower and more restricted. The
majority of tissues examined express all three genes (Table 1.1) and these results are broadly
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consistent with the published analyses of LPP RNA distribution and, in cases where
appropriate antibodies are available, protein expression (Hooks et al., 1998; Kai et al., 1996;
Kai et al., 1997; Sciorra and Morris, 1999). cDNAs encoding apparent splice variants of
LPP1 and LPP2 with alternate N-terminal sequences and truncated C-termini have been
deposited in GenBank (Nanjundan and Possmayer, 2003). Two of these cDNAs encode
proteins lacking a complete catalytic domain. However, it is presently not known if proteins
corresponding to these variant cDNAs are actually expressed so the significance of these
findings remains unclear. The subcellular localization of LPPs has been examined in a
number of different cell types by overexpression of epitope tagged variants or, in a smaller
number of cases, endogenously expressed LPPs have been visualized by indirect
immunofluorescence using selective antibodies (Alderton et al., 2001a; Jasinska et al., 1999;
Jia et al., 2003; Sciorra and Morris, 1999). The proteins predominantly localize to the
endoplasmic reticulum and plasma membrane with possible localization to other
endomembrane compartments including the Golgi apparatus and endosomes also noted.
Increases in intact cell lipid phosphatase activity against exogenously applied substrates
observed in cells overexpressing LPP1 and LPP3 are also consistent with localization to the
plasma membrane (Jasinska et al., 1999; Roberts and Morris, 2000; Zhao et al., 2005).
Biochemical fractionation experiments indicate that LPP1 and LPP3 exhibit cell-specific
localization to detergent resistant membrane domains which are considered to represent lipid
rafts or caveolae (Nanjundan and Possmayer, 2001; Sciorra and Morris, 1999). Recruitment
of LPPs to these membrane domains may be an important way to compartmentalize them
with LPA or S1P receptors or with lipid signaling enzymes, particularly phosphatidylcholine-
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specific phospholipase D (PLD) enzymes which are also found in caveolae and raft domain
membranes (Czarny et al., 1999).
Two major functions have been proposed for the LPPs. Firstly, they have been
suggested to have roles in regulation of intracellular lipid metabolism by controlling the
balance between PA and DG with obvious consequences for both cell signaling and influence
on the synthesis of choline and inositol containing phospholipids. Although overexpression
of LPP1 (Alderton et al., 2001a; Leung et al., 1998; Leung et al., 1999; Yue et al., 2004) and
overexpression (Sciorra and Morris, 1999) or knock out (Escalante-Alcalde et al., 2003) of
LPP3 clearly have effects on intracellular lipid metabolism in some, but not all cells, the
mechanism and significance of these observations remain largely unexplored. In this regard,
perhaps the most interesting possible function for LPPs in intracellular lipid metabolism and
signaling involves hydrolysis of PA generated by PLD. In this situation, LPP activity would
terminate PLD signaling by hydrolysis of PLD-generated PA, concurrently forming DG
which could activate lipid-responsive protein kinase C isoforms. In support of this idea,
overexpression of LPP3 was shown to enhance PLD-dependent production of DG possibly as
a result of co-localization of LPP3 with a specific PLD isoenzyme, PLD2, in detergent
insoluble lipid raft domains (Sciorra and Morris, 1999). Similarly, the Raf protein kinase
appears to be a signaling target of PLD-generated PA, and overexpression of LPP1 and LPP2
attenuates activation of the downstream Raf effector MAPK (mitogen-activated protein
kinase) (Alderton et al., 2001a). Secondly, by virtue of their localization to the plasma
membrane in many cell types (Alderton et al., 2001b; Jasinska et al., 1999; Jia et al., 2003;
Roberts et al., 1998; Roberts and Morris, 2000; Sciorra and Morris, 1999) and their
demonstrated ability to function as ecto enzymes that dephosphorylate bioactive lipids with
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receptor-directed signaling actions, such as LPA and S1P (Jasinska et al., 1999; Roberts et
al., 1998; Roberts and Morris, 2000; Smyth et al., 2003), LPPs have been proposed to
function as negative regulators of receptor-directed signaling by these bioactive lipid
mediators. Experimental data, based in large part on overexpression studies and to a lesser
extent on loss of function experiments using antisense RNA and pharmacological inhibitors,
support this idea. The role of LPPs in regulation of signaling by cell surface
lysophospholipid receptors has been reviewed elsewhere (Brindley, 2004; Brindley et al.,
2002; Nanjundan and Possmayer, 2003; Sciorra and Morris, 2002) and will not be discussed
further here.
LPP3 knock out mice exhibit defects in patterning during early development- It
is perhaps more interesting that attempts to ascribe functions to the mammalian LPPs at a
cellular and organismal level are beginning to reveal unexpected functions, some of which
may not directly involve their catalytic activities. The broad and overlapping expression
patterns of the three LPPs (Table 1.1) suggest that their functions may be non-redundant, and
consistent with this idea mice lacking LPP2 are viable and were reported to exhibit no overt
phenotype (Zhang et al., 2000a). Inactivation of LPP1 in mice has not yet been reported.
However, transgenic overexpression of LPP1 under control of a ubiquitously active actin
promoter produced a runted phenotype with defects in spermatogenesis and fur growth.
Circulating levels of LPA in the blood of these animals were not different from those
measured in wild type mice, and their phenotype was suggested to result from effects on the
intracellular accumulation of DG which was observed in LPP1 overexpressing cell lines
derived from these animals (Yue et al., 2004). In marked contrast to the relatively benign
effects of manipulating LPP1 and LPP2 expression in mice, homozygous inactivation of the
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murine LPP3 gene results in early embryonic lethality and a complex phenotype
characterized by defects in both vasculogenesis and patterning during early development
(Escalante-Alcalde et al., 2003). The duplication of axis symmetry observed in embryos
from LPP3 null mice is similar to that observed when the wnt signaling pathway is activated,
for example, by ectopic embryonic overexpression of Wnts (Popperl et al., 1997). This
phenotype also results from inactivation of axin, which is a scaffolding protein functioning as
a negative regulator of wnt signaling by binding activated -catenin (Zeng et al., 1997).
Experiments using cells derived from LPP3 null mice reveal a novel role for LPP3 as a
negative regulator of the wnt signaling pathway. Expression of a Wnt reporter gene
construct was higher in LPP3 null cells than in wild-type cells, whereas ectopic expression of
LPP3 in LPP3 null cells reduced Wnt signaling activity to wild-type levels and concurrently
reduced nuclear translocation of -catenin (Escalante-Alcalde et al., 2003). The mechanism
by which LPP3 inhibits wnt signaling is currently not known. In addition to the "canonical"
Wnt signaling pathway, Wnts also activate a phospholipase C-coupled pathway leading to
protein kinase C (PKC) activation (Kuhl et al., 2000b). Overactivation of this “Wnt/Ca2+”
pathway results in attenuation of the canonical Wnt signaling pathway and a ventralizing
phenotype (Kuhl et al., 2000a) which is very similar to that seen when mammalian LPP3 was
ectopically expressed in Xenopus embryos (Escalante-Alcalde et al., 2003). As noted above,
overexpression of LPP3 has been shown to result in increased levels of DG in cells (Sciorra
and Morris, 1999), and DG levels were decreased in LPP3 null cells with a concurrent
decrease in activated PKC, which might, in turn, result in a stimulation of the canonical wnt
signaling pathway. On the other hand, studies using catalytically inactive LPP3 mutants
indicate that the ability of overexpressed LPP3 to suppress Wnt signaling in LPP3 null cells
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is, at least partially, independent of enzymatic activity, implying the involvement of an
alternate, as yet unidentified, mechanism (Escalante-Alcalde et al., 2003). Although
overexpression of a catalytically inactive mutant of LPP1 has been shown to attenuate LPA-
stimulated cytokine secretion in bronchial airway cells (Zhao et al., 2005), the only “non-
enzymatic” function suggested for LPP3 is regulation of cell-cell interactions by an integrin-
binding RGD (Arg-Gly-Asp) sequence present in the third extramembrane loop (Humtsoe et
al., 2003). Although this finding is provocative in light of the involvement of LPP3 in Wnt
signaling, which can also be regulated though another cell surface adhesion molecule, p120
catenin, its broad relevance for mammalian LPP3 function is questionable, because the
cognate sequence in murine LPP3 is RGE (Arg-Gly-Glu), which would not be expected to
bind integrins.
Drosophila LPPs regulate germ cell migration and survival during early
development- Studies in Drosophila have identified roles for two LPP homologs, the
products of the wunen genes wun and wun2, in regulation of embryonic germ cell migration
and survival (Starz-Gaiano et al., 2001; Zhang et al., 1996; Zhang et al., 1997). Drosophila
germ cells form at the posterior pole of the developing embryo and are swept into the hind
gut and posterior mid gut during gastrulation. The germ cells then move across the mid gut,
reorient dorsally and migrate into the mesoderm to associate with the somatic gonadal
precursor cells (Forbes and Lehmann, 1999; Starz-Gaiano et al., 2001; Starz-Gaiano and
Lehmann, 2001). Wun and wun2 act redundantly as repellant factors to guide migrating
germ cells in the Drosophila embryo. These genes are normally expressed in somatic tissues
that the germ cells avoid. However, in wunen mutants in which both genes are disrupted the
germ cells scatter throughout the embryo, failing to reach the mesoderm and eventually die.
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By contrast, overexpression of wun or wun2 in somatic tissues such as the mid gut and
mesoderm that normally attract germ cells results in germ cell repulsion and death (Starz-
Gaiano et al., 2001; Zhang et al., 1997). The repulsive effect of these LPPs on germ cell
migration has been suggested to be a result of their ability to degrade a lipid factor that both
guides germ cells and serves as a germ cell survival factor during their migration in the
developing gut. However, while both wun and wun2 are functional LPPs whose enzymatic
activity is necessary for their ability to repel germ cells (Burnett and Howard, 2003; Starz-
Gaiano et al., 2001), the chemical identity of this lipid signal has not yet been determined.
The finding that mammalian LPP3 can also repel germ cells when expressed in the somatic
cells of Drosophila embryos indicates a conserved function between insect and mammalian
LPPs, although surprisingly mammalian LPP1 cannot repel germ cells in this assay (Burnett
and Howard, 2003; Renault et al., 2004). The basis for this difference in biological activity
between LPP3 and LPP1 is not known. While their substrate specificities and enzymatic
activities are very similar in vitro, these two LPPs have been shown to localize selectively to
the apical and basolateral surface of polarized cells (Jia et al., 2003) and LPP3 has also been
reported to localize to detergent resistant membrane domains (Sciorra and Morris, 1999), so
it is possible that differences in subcellular localization or, perhaps, regulation of these LPPs,
rather than in their intrinsic enzymatic activity or substrate selectivity, accounts for their
distinct effects on germ cell migration when expressed in Drosophila embryos. Interestingly,
wun and mammalian LPP1 and LPP3 were recently shown to form stable homodimers
through interactions requiring the C-termini of the proteins in overexpression experiments
conducted using epitope-tagged proteins (Burnett et al., 2004). While, at least in the case of
wun, this interaction did not appear to have functional relevance, these findings raise the
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possibility that interactions between LPPs may modulate their localization or activities in
some settings (Burnett and Howard, 2003).
A recent study identifies a novel and surprising additional role for wun2 as a germ
cell specific factor required for proper germ cell migration and survival (Renault et al.,
2004). Wun2 is specifically expressed in germ cells of the developing Drosophila embryo
from maternally inherited RNA. Expression of catalytically active wun2 in germ cells is
required for germ cell survival in otherwise wild-type embryos and, as in the germ cell
repulsion assays described above, when expressed in germ cells, LPP3 can substitute for
wun2. Germ cell-specific expression of wild type but not catalytically inactive alleles of
Wun2 or of mammalian LPP3 could suppress germ cell death resulting from somatic
overexpression of wun2. Wun2 therefore exhibits paradoxical cell- and tissue- specific
effects on germ cell survival. When expressed in germ cells, wun2 promotes their survival
while expression of either wun2 or wun in somatic cells repels migrating germ cells and
promotes germ cell death. Experiments in which expression levels of wun2 in germ cells or
somatic cells were separately regulated revealed a reciprocal relationship between the actions
of wun 2 in germ cells and somatic cells. Germ cell death induced by somatic
overexpression of wun2 could be suppressed by overexpression of wun2 in germ cells, while
germ cell death resulting from a lack of maternally expressed germ cell wun2 could be
rescued by reducing somatic wun2 expression. These results suggest a model in which
somatic wun and wun2 compete with germ cell wun2 for a common lipid substrate. While
hydrolysis of this substrate in the soma results in decreased germ cell survival, hydrolysis of
the substrate by germ cells promotes their survival. As noted above, both wun and wun2 are
active LPPs with substrate specificities and catalytic properties that are very similar to those
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of the mammalian LPPs (Burnett and Howard, 2003; Renault et al., 2004). As was observed
for mammalian LPP1 (Roberts and Morris, 2000), overexpression of wun2 in cultured insect
cells results in a significant enhancement of cellular accumulation of lipid dephosphorylation
products when the cells are incubated with fluorescent analogs of PA (Renault et al., 2004).
Hydrolysis-coupled intracellular accumulation of PA dephosphorylation products has been
described in mammalian cells (Pagano et al., 1981; Perry et al., 1993). This phenomenon
may involve partitioning of the lipid substrate into the plasma membrane where LPP-
catalyzed hydrolysis generates a non polar lipid product, DG, which can enter the cell by
endocytosis where it becomes susceptible to further metabolism. It is therefore plausible
that, although the activities of wun and wun2 in the soma may be linked to degradation of a
pool of a lipid phosphate substrate that is required for germ cell guidance and survival, the
germ cell-specific action of maternally inherited wun2, which is necessary for germ cell
survival, is linked to wun2-facilitated lipid uptake and the intracellular accumulation of a
bioactive lipid signaling molecule. In light of the apparent absence of G-protein coupled
lysophospholipid receptors from the Drosophila genome (Hla et al., 2001; Renault et al.,
2002), it is possible that the ability to facilitate lipid uptake might represent a primary
signaling function for wun and/or wun2. Clearly, the identification of the relevant lipid
substrate hydrolyzed by wun/wun2 in the somatic and germ cells of Drosophila embryos
remains a major challenge. The possibility that mammalian LPPs also have signaling
functions that are coupled to the intracellular accumulation of lipid dephosphorylation
products is also an area worth examining further.
6. SPHINGOSINE PHOSPHATE PHOSPHATASES
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Structural organization and enzymology- The identification of the mammalian
SPPs was preceded by studies of yeast genes that encode enzymes that dephosphorylate
phosphorylated sphingoid bases and termed YSR3/LBP2 and YSR2/LBP1/LCB3 (Mao et al.,
1997). These yeast enzymes are non-redundant and both exhibit high phosphatase activity
against long chain sphingoid base phosphates. Although SPP1 has been characterized in
most detail, in contrast to the broad specificity of LPPs1-3 for lipid phosphomonoester
substrates, SPP1 and 2 are highly selective for S1P (Le Stunff et al., 2002c; Ogawa et al.,
2003). Another notable enzymatic difference between the LPP and SPP enzymes is that,
whereas the LPPs are most active against detergent solubilized substrates, the SPPs are
inhibited by detergents and show a marked preference for substrates that are bound to a
protein carrier (Le Stunff et al., 2002b; Mandala et al., 2000). As noted above, SPPs contain
a consensus phosphatase/phosphotransferase catalytic motif with a minor substitution in the
C2 sequence but, in contrast to the LPPs, their C-terminus is much longer and, may contain
an additional two transmembrane spans.
Expression, localization and functions- SPP1 and SPP2 have broad and partially
overlapping expression patterns in mammalian tissues. Expression of SPP2 appears more
widespread than SPP1 (Ogawa et al., 2003) (Table 1.1). Like the LPPs, it has proven
difficult to generate effective antibodies against mammalian SPPs, so overexpression studies
using epitope-tagged proteins have been used to investigate their subcellular localization. In
contrast with the LPPs which are broadly localized to both endomembrane compartments,
primarily the endoplasmic reticulum, and to the plasma membrane, SPP1 and SPP2 are
restricted to the endoplasmic reticulum (Le Stunff et al., 2002c; Ogawa et al., 2003), which is
similar to the subcellular localization of their yeast counterparts (Mao and Obeid, 2000).
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Ideas about the function of these enzymes therefore emphasize the possibility that they have
roles in intracellular sphingolipid metabolism, in particular generation of sphingosine for
ceramide synthesis, rather than a primary direct role in the inactivation of S1P at the cell
surface and consequent termination of its signaling actions, which, as discussed above, is a
more likely potential function for the LPPs. The most detailed information about SPP
function comes from studies in yeast, which are now being extrapolated to mammalian cells.
Yeast sphingolipids are structurally analogous to mammalian sphingolipids, except that the
polar head group is phosphoinositol, whereas phytosphingosine is the predominant sphingoid
base, as opposed to choline and sphingosine respectively. Yeast sphingolipids, in particular
ceramide, have well-defined functions in protection from heat, osmotic and low pH stresses
(Obeid et al., 2002). Deletion of LBP1 and LBP2 results in a marked accumulation of
phosphorylated sphingoid bases, a concomitant reduction in ceramide levels and a dramatic
increase in resistance to these stresses. Conversely, overexpression of LBP1 results in
ceramide accumulation and increased sensitivity to stress (Mao et al., 1997). Mutational
analysis and suppressor screens demonstrate that LBP1p functions to control the balance
between sphingoid bases, which are used for sphingolipid synthesis, and phosphorylated
sphingoid bases, which are recycled for phospholipid synthesis. Interestingly, LBP1 mutants
are also unable to incorporate exogenously supplied sphingosine into sphingolipids, which
suggests that phosphorylation and dephosphorylation of these lipids is somehow required for
their use as precursors for ceramide synthesis (Mao et al., 1999; Obeid et al., 2002). Studies
in mammalian cells reveal an analogous role for SPP1 in control of ceramide levels and
apoptosis, but suggest additional roles for the mammalian SPPs in control of sphingolipid
metabolism and signaling.
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SPPs regulate survival, apoptosis and migration in mammalian cells- Forced
overexpression of SPP1 results in significantly increased levels of intracellular ceramide.
This SPP1-dependent increase in ceramide levels can be enhanced further by exogenous
application of S1P that presumably enters the cells and is dephosphorylated by SPP1 at the
endoplasmic reticulum to generate sphingosine, which in turn serves as a substrate for
ceramide biosynthesis (Le Stunff et al., 2002a). In mammalian cells, a substantial body of
evidence identifies ceramide as an intracellular signal for stress-induced apoptosis (Hannun
and Obeid, 2002). The increased levels of ceramide observed in SPP1 overexpressing cells
were associated with reduced cell survival and increased apoptosis (Le Stunff et al., 2002a;
Mandala et al., 2000). A curious observation from these experiments was that, although an
equally good substrate for SPP1, exogenous application of dihydro-S1P had no effect on
intracellular ceramide levels or apoptosis. These interesting findings imply different roles for
ceramide and dihydroceramide in sphingolipid synthesis and regulation of apoptosis,
possibly related to trafficking of ceramide and dihydroceramide between different
endomembrane compartments that serve as sites for the synthesis and actions of these lipids
(Le Stunff et al., 2002a; Le Stunff et al., 2002b). Although mouse knock-out models of SPP1
have not yet been reported, RNA interference studies conducted in mammalian cells reveal a
role for SPP1 in control of levels of S1P, both within cells and extracellularly, and suggest an
addition mechanism by which SPP1 could regulate apoptosis. Knock-down of SPP1 resulted
in significant accumulation of both intra- and extra-cellular S1P, suggesting that SPP1
activity normally opposes the synthesis of S1P by sphingosine kinase. Suppression of SPP1
expression in these cells rendered them resistant to apoptosis induced by TNF (tumor
necrosis factor) and chemotherapy drugs (Johnson et al., 2003). Through actions mediated
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by specific G-protein-coupled cell surface receptors, S1P is a potent and effective survival
factor for many mammalian cells (Hla et al., 2001), so it is reasonable to postulate that the
resistance to apoptosis observed when SPP1 expression is suppressed results from an
enhancement of S1P signaling (Johnson et al., 2003). These results raise the possibility that
the increases in apoptosis associated with overexpression of SPP1 may result from a decrease
in S1P levels, rather than increases in ceramide levels as suggested above. These competing
ideas are not mutually exclusive and clearly this issue will require further experimentation to
resolve. For example, one critical consideration is that the extracellular levels of S1P that
result in increased intracellular accumulation of ceramide are much higher than the levels
required to promote cell signaling responses through actions mediated by S1P receptors. It is
also unclear if these effects on intracellular sphingolipid metabolism are restricted to the
SPPs or if overexpression of one or more of the LPPs, which can both dephosphorylate S1P
and localize to the endoplasmic reticulum in many cells, can also increase intracellular levels
of ceramide or regulate levels of S1P inside and outside of cells. It is also important to note
that all of these studies have focused on SPP1 and, although it is clearly an active S1P
phosphatase in vitro, the cellular functions of SPP2 also need to be examined.
7. SPHINGOMYELIN SYNTHASES
Structure and enzymology- The sole pathway for sphingomyelin synthesis in
mammalian cells involves the enzymatic transfer of the phosphocholine group of
phosphatidylcholine to ceramide generating sphingomyelin and diacylglycerol (Voelker and
Kennedy, 1982). The enzyme responsible, sphingomyelin synthase (SMS), therefore
occupies a central position at a crossroads of sphingolipid and phospholipid metabolism. The
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actions of this enzyme not only generate sphingomyelin but regulate cellular levels of the
signaling lipids DG and ceramide (Hannun and Obeid, 2002; Luberto and Hannun, 1998).
However, despite the pivotal role of this membrane-associated activity in both phospho- and
sphingolipid metabolism, the enzymes responsible for this reaction in mammalian cells were
only identified very recently. Studies published in the past year have identified a family of
two animal SMSs termed SMS1 and SMS2 (Huitema et al., 2004). These are integral
membrane proteins that, as discussed in detail above, have the common six transmembrane
spanning core domain topology common to the LPT family. SMS1 and SMS2 contain the
C2 and C3 catalytic motifs which are likely to be responsible for the phosphotransferase step
of catalysis, whereas the C1 motif is absent and replaced by unique SMS-specific sequence
motifs that are likely to be responsible for substrate recognition and orientation in the active
site (Huitema et al., 2004) (Figures 1.2–1.4). SMS1 and SMS2 were identified using a
candidate gene expression cloning strategy. The essential S. cerevisiae Aur 1 gene product
catalyses the transfer of the headgroup of phosphatidylinositol to phytoceramide, generating
inositol-phosphorylceramide and DG (Dickson and Lester, 1999; Nagiec et al., 1997).
BLAST searches for novel sequences encoding integral membrane proteins containing the
C2 and C3 domain common to Aur1p and LPPs without homologues in yeast or previously
characterized biochemical functions identified three groups of candidate genes with
homologues in multiple animal species (Huitema et al., 2004). Epitope-tagged variants of
these proteins were expressed in yeast, and SMS activity was determined in vitro using
membrane extracts as a source of activity by monitoring the incorporation of fluorescent
ceramide into SM which proceeds using endogenous membrane PC as a substrate. Two of
the human proteins tested, SMS1 and SMS2, were active in these assays. SMS activity could
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be observed using exogenously provided PC, but not lyso-PC, choline, phosphorylcholine or
nonphosphocholine lipids, including phosphatidylethanolamine, suggesting that the enzyme
recognizes the two acyl chains attached to the phosphocholine headgroup. Interestingly, in
these experiments, SM itself could also serve as a headgroup donor, indicating that, as
observed previously using membrane preparations as a source of enzyme activity (Marggraf
and Kanfer, 1984), the SMS reaction is reversible. A subsequent publication reported
expression cloning of SMS1 using an equally elegant complementation strategy employing
mammalian cell lines with previously described defects in SMS activity. This study is of
importance as it demonstrated that SMS1 is functional when expressed in intact cells
(Yamaoka et al., 2004). As noted above and consistent with the presence of SM in many
organisms, SMS homologues are found in many species. Drosophila, which lacks SM, but
instead synthesizes ethanolamine phosphoceramide, is a notable exception. Although the
Drosophila genome does not contain SMS homologues, a single SMS-related gene was
identified that might encode an ethanolamine phosphotransferase responsible for
ethanolamine phosphoceramide synthesis (Huitema et al., 2004).
Localization and function- Prior to the identification of the SMS genes,
fractionation studies suggested that SMS activity was associated with both the Golgi
apparatus and plasma membrane (Futerman et al., 1990; van Helvoort et al., 1994). In
agreement with these findings, indirect immunofluorescence analysis of epitope-tagged
SMS1 and SMS2 in HeLa cells revealed two distinct localization patterns. SMS1 was
mainly found at the Golgi apparatus, whereas SMS2 displayed a predominantly plasma
membrane localization and only partial co-localization with the Golgi marker
sialyltransferase (Huitema et al., 2004). The C-terminally appended V5 epitope tag of SMS2
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was insensitive to proteolysis when trypsin was added to intact cells, but could be readily
degraded when the plasma membrane was permeabilized with detergent. This finding implies
that, as is the case with other LPT family members, the C-termini of SMS are oriented
towards the cytosol, whereas the active sites are directed towards the lumen of the Golgi
apparatus or the extracellular space (Huitema et al., 2004). The orientation and localization
of SMSs suggest that SMS1 may have a primary ‘housekeeping’ role in SM synthesis within
the cell, whereas SMS2 could have a lipid signaling function at the plasma membrane,
possibly working in conjunction with sphingomyelinases to regulate plasma membrane levels
of the pro-apoptotic signaling lipid ceramide. Nothing is presently known about how SMS1
and SMS2 activity is regulated. In light of the reversibility of the SMS reaction, it is possible
that the relative concentrations of DG and ceramide resulting from the actions of
phospholipases C and sphingomyelinases in the vicinity of SMS are a relevant determinant of
the direction and rate of the SMS reaction. In this regard it is interesting to note that up- and
down-regulation of SMS activity has been linked to mitogenic and pro-apoptotic signaling in
several mammalian cell types (Hannun and Obeid, 2002). The identification of SMS1 and
SMS2 provides unique tools to investigate the regulation and functions of these long-sought
enzymes.
8. LIPID PHOSPHATASE RELATED PROTEINS/PLASTICITY RELATED GENES
Structure and enzymology- In comparison with other members of the LPT family,
the four members of the LPR/PRG family are characterized by incomplete conservation of
the C1, C2 and C3 catalytic motif sequences. As mentioned above and illustrated in Figure
1.3, these proteins share a non-conservative substitution of the C3 nucleophilic histidine
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residue and of the C1 lysine and arginine residues, and there are additional non-conservative
substitutions of the C2 motif residues in some LPR/PRG family proteins. The proposal that
these genes are termed lipid phosphatase related (LPR) proteins (Brindley, 2004; McDermott
et al., 2004; Sigal et al., 2007) was intended to reflect this incomplete structural relationship
to the LPPs and other LPT family members. One of these genes, LPR3, was cloned from a
rat brain cDNA library and given the name PRG1 to reflect the regulation of its expression
during brain development and response to experimentally induced hippocampal lesions
(Brauer et al., 2003). In agreement with this nomenclature, the other members of this gene
family have been termed PRG2, 3 and 4 (Savaskan et al., 2004). The LPR nomenclature has
been adopted by GenBank, because of the pre-existing use of the acronym “PRG” for an
unrelated family of secreted proteoglycan genes (Avraham et al., 1988). For clarity and
consistency we refer to these as “LPR/PRG” proteins in the rest of this chapter. Ideally, this
imprecise terminology will soon be replaced by a nomenclature that reflects the biological
functions of these proteins. The incomplete conservation of the catalytic motif in all of the
LPR/PRG proteins, and, in particular, the non-conservative substitution of amino acid
residues that are critical for catalysis in other LPT family members, implies that none of the
LPR/PRG proteins could catalyze lipid phosphatase or phosphotransferase reactions using
the mechanism discussed in detail above (Figures 1.3 and 1.4). Consistent with this
prediction, LPR/PRG proteins do not have SMS activity when expressed in yeast (Huitema et
al., 2004), and two of these proteins, LPR1/PRG3 and LPR3/PRG1 do not have LPA
phosphatase activity when expressed in HEK 293 cells or in SF9 cells, and assayed using
either intact cells or cell membranes as the source of enzyme activity (McDermott et al.,
2004; Sigal et al., 2007). These experiments were conducted using a highly sensitive
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“phosphate-release” assay with [32P]-labeled substrates, or a less sensitive assay in which the
formation of radiolabelled monoacylglycerol by hydrolysis of acyl chain labeled LPA
substrate was monitored under conditions where activity of a co-expressed LPP could be
readily detected. Both the LPR/PRG proteins and the control LPP protein were expressed to
similar levels, as shown by Western blotting using antibodies against an appended C-terminal
tag. In accordance with these findings, overexpression of LPR1/PRG3 in a cultured neuronal
cell line did not result in increases in the rate of hydrolysis of exogenously added LPA by
intact cells (Savaskan et al., 2004). Paradoxically, however, overexpression of LPR3/PRG1
has been reported to result in variable increases in rates of LPA hydrolysis (either 5-fold or 2-
fold compared with the control) in the same neuronal cell line (Brauer et al., 2003; Savaskan
et al., 2004). Given the inactivity of LPR3/PRG1 in more carefully controlled experiments
(McDermott et al., 2004), if these observations can be substantiated by others, one
explanation may be that overexpression of LPR3/PRG3 in some cells results in an
upregulation of the activity of endogenously expressed LPPs at the cell surface. As
discussed in more detail below, resolution of this issue is critical to our understanding of the
biological activities of these LPR/PRG proteins. The other noteworthy structural feature of
the LPR/PRG proteins is the very long C-terminus (approx. 400 amino acids) found in
LPR3/PRG1 and LPR4/PRG2, which is unique among the entire LPT family. This region of
the proteins is highly enriched in charged amino acid residues and contains so called proline,
glutamic acid, serine and threonine-containing (PEST) sequences that, in other proteins,
function as signals for ubiqutin-dependent targeting for proteolytic degradation (Rechsteiner
and Rogers, 1996). Multiple species of C-terminally tagged LPR3/PRG1 are detected when
the protein is overexpressed in mammalian cells, suggesting that proteolysis may be a highly
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relevant mechanism for regulation of the turnover and expression levels of the protein
(McDermott et al., 2004). Inspection of both EST sequences and genomic sequences for
LPR3/PRG1 and LPR4/PRG2 provides evidence for the existence of splice variants with
alternative C-termini, which may provide an additional mechanism for regulating the
biological activities of these proteins.
Expression, localization and functions- In contrast with the LPPs and SPPs, the
individual members of the LPR/PRG family exhibit much more restricted expression
patterns. Northern blot analysis showed that LPR3/PRG1 was most strongly expressed in the
brain, although weaker expression in peripheral tissues was also apparent, which is consistent
with the tissue distribution of corresponding ESTs with transcripts found in the eye, kidney
and ovary (Brauer et al., 2003). LPR4/PRG2 is more widely expressed than LPR3/PRG1.
Similarly, LPR1/PRG3 exhibits a more restricted expression pattern than LPR2/PRG4 (Table
1.1). The distinct and, in many cases, non-overlapping expression patterns of the LPR/PRG
genes suggests that they may not function redundantly. Characterization of the LPR/PRG
proteins is at an early stage. Overexpression of wild-type LPR3/PRG1, but not of an
LPR3/PRG1 mutant containing a non-conservative substitution of one amino acid residue
that is conserved within the LPT C2 catalytic motif and known to be critical for catalysis in
the LPPs, was reported to protect cultured neuronal cells from the neurite-collapsing actions
of exogenously applied LPA. In conjunction with the finding that neuronal expression of
LPR3/PRG1 is increased during brain development and regenerative sprouting of axons and
neurites induced in response to hippocampal injury, these observations were suggested to
identify a normal role for LPR3/PRG1 as a regulator of these kinds of neuronal membrane
protrusions during brain development and responses to injury through the localized
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attenuation of LPA signaling (Brauer et al., 2003). Clearly identification of the mechanism
by which overexpression of LPR3/PRG1 apparently increases rates of dephosphorylation of
exogenously provided LPA is of critical importance to understanding this phenomenon.
More importantly, this suggestion implies that endogenously-formed LPA has a normal role
in regulation of neuronal plasticity, which is an interesting, but as yet unproven idea (Ishii et
al., 2004; Ye et al., 2002). Further testing of these interesting ideas regarding LPR3/PRG1
function will require loss-of-function approaches and the identification of the LPA receptors
responsible for these putatively LPR3/PRG1-regulated signaling pathways. In apparent
contrast with these effects of the overexpression of LPR3/PRG1 on neurite outgrowth,
overexpression of LPR1/PRG3 was reported to cause the spontaneous outgrowth of
structures suggested to be ‘neurites’ by cultured neuronal cells and COS-7 cells (Savaskan et
al., 2004). The true identity of these membrane protrusions, which we have identified as
filopodia (Sigal et al., 2007), a description of their composition and dynamics is examined in
chapter 3 of this document. Because overexpression of LPR1/PRG3 does not result in
increases in rates of dephosphorylation of exogenously provided LPA (McDermott et al.,
2004; Savaskan et al., 2004; Sigal et al., 2007), these observations imply that overexpression
of LPR1/PRG3 can induce changes in cell morphology through processes that do not involve
attenuation of LPA signaling, as was suggested for LPR3/PRG1. Taken together, these
studies show that two members of the LPR/PRG family have a role in regulation of cellular
morphology. However, the mechanistic basis for this surprising activity is presently not
known. In light of their primary sequence and inactivity in properly controlled experiments,
the most parsimonious conclusion is that none of the LPR/PRG proteins have intrinsic lipid
phosphatase or phosphotransferase activity, which raises the question of whether they are
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enzymes at all. As has been found for other classes of proteins and lipid phosphatases, an
intriguing possibility is that the LPR/PRG proteins are “non-enzymes” – catalytically
incompetent homologues of active enzymes lacking residues critical for catalysis, but
retaining residues required for the capacity to interact non-productively with their lipid
substrates (Todd et al., 2002). For example, enzymatically inactive homologues of the
phosphoinositide phosphatase, myotubularin, can still bind D-3 phosphorylated inositol lipids
and function as adapter proteins (Nandurkar et al., 2001). Although the identified G-protein-
coupled LPA receptors clearly account for may of the identified signaling actions of LPA,
genetic and pharmacological data imply that additional mechanisms of LPA signaling exist
(Luquain et al., 2003a). Perhaps the LPR/PRG proteins can interact with LPA, S1P or a
related lipid-signaling molecule and have ‘receptor-like’ activities that are coupled to
pathways that regulate cell morphology? Whatever the case, these fascinating new proteins
are a very attractive area for future studies.
9. TYPE 2 CANDIDATE SPHINGOMYELIN SYNTHASES.
Structure and enzymology- The final group of LPT family proteins contains two
members. These proteins have been provisionally termed CSS2s (Huitema et al., 2004), but,
aside from a report that they do not exhibit SMS activity when overexpressed in yeast, their
enzymatic activities are unexplored. One of these proteins, CSS2 contains a completely
conserved phosphatase motif that is identical with that found in the LPPs, which strongly
suggests that it may be a functional phosphatase. CSS2 contains a variant phosphatase
motif that is, in some respects, similar to the apparently inactive phosphatase motif found in
the LPR/PRG proteins. Clearly, the potential enzymatic activities of these proteins need to
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be investigated directly. In comparison with other LPT family members, the defining shared
structural characteristic of the CSS2 proteins is an extended N-terminus preceding the first
transmembrane domain. This region is approximately 80 amino acids long and quite
divergent between the two proteins, although a short motif close to the transmembrane
domain is well conserved. Hydropathy analysis of these proteins also predicts the presence
of six transmembrane -helices, although it is noteworthy that the putative extramembrane
loop sequence between helices 4 and 5 is very short, suggesting that these two helices may
not span the plasma membrane completely, perhaps forming a single ‘half-membrane-
spanning’ helix, as has been observed in some aquaporin family channel proteins (Stroud et
al., 2003).
Expression, localization and functions- Analysis of EST abundance reveals that
CSS2 is widely expressed in mammalian tissues, whereas CSS2 has a more restricted
expression pattern (Table 1.1). Intriguingly, a subtractive proteomic screen suggests that
CSS2 localizes, at least partially, to the nuclear envelope (Schirmer et al., 2003). The
strategy used to isolate proteins for sequencing in this study implies that CSS2 is at least
partially resistant to extraction of the nuclear membrane with non-ionic detergents,
suggesting that nuclear envelope localization and retention of the protein involves an
interaction with a component of the nuclear lamina or matrix. The nuclear envelope proteins
sequenced in this screen were obtained from liver which appears to only express CSS2
(Table 1.1), therefore clearly the subcellular localization of both CSS2 and CSS2 needs to
be evaluated directly. The apparent nuclear envelope localization of at least one of the CSS2
proteins is provocative, because, although LPP activity has not been explored explicitly in
isolated nuclei, both direct and indirect biochemical observations of enzyme activities that
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can generate DG from PA in nuclei have been reported (D'Santos et al., 1999; Vann et al.,
1997). A growing body of work identifies roles for glycerophospholipids in both the nuclear
matrix and surrounding membrane as regulators of aspects of nuclear function that include
signal transduction and regulation of nuclear RNA export (Irvine, 2003). The possibility that
one or both of the CSS2 proteins functions in nuclear phospholipid metabolism linked to
control of these, and possibly other nuclear functions, is worth considering.
Figure 1.5 Subcellular Localization and Functions of LPT Family Members. The
localization of the CSS2 proteins to the nuclear envelope is speculative and based on results obtained
from a subtractive proteomic screen conducted using rat and mouse liver-derived subcellular
fractions. The subcellular localizations of other LPT family members are based on published reports
that, for the most part, involve studies using overexpressed epitope tagged proteins.
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10. CONCLUDING COMMENTS
Figure 1.5 summarizes ideas presented in this review about the subcellular
localization and possible functions of the different classes of LPT proteins. It is important to
stress that the information presented in Figure 1.5 comes from a relatively small number of
studies conducted using divergent cell types and relying to a great extent on overexpression
approaches. Moreover, some of the ideas presented, in particular about the localization and
functions of the LPR/PRG and CSS2 proteins are admittedly speculative, but incorporate
what limited information is presently available. Nevertheless, the observations and ideas
brought together in this figure suggest roles for members of the LPT family in aspects of
lipid metabolism and signaling that involve all major endomembrane systems of the cell.
The advances discussed in this chapter promise to stimulate the application of more
sophisticated approaches to the analysis of the function of the LPT family proteins in cells
and animals. Investigators now have molecular tools to examine the phenotypic
consequences of down-regulation and overexpression of these proteins, and can employ
genetic and mutational approaches to dissect the structural basis for their activities. As
integral membrane proteins, segregation and sorting of LPT family members to different
membrane compartments is clearly of great importance for understanding their cellular
functions, and this issue can now be explored by the construction and analysis of epitope-
tagged variants of the proteins. In particular, members of the LPP, SPP and SMS families
are highly amenable to C-terminal tagging with green fluorescent protein, which can be used
to investigate their localization and trafficking in live cells. Although many important
questions can now be addressed using cell culture systems, analysis of LPT family gene
function at the organismal level is now possible. The use of knock-out technology to probe
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the function of LPT family members in multicultural organisms is at a very early stage. The
lessons learned from the work on murine LPP2 and LPP3 and the Drosophila wunen genes
indicate that, although there is may be some functional redundancy between members within
a particular class of LPT proteins, this is likely to continue to be a very fruitful and
productive approach. These gene inactivation approaches would benefit from the
identification of homologues in simpler genetically manipulatable organisms, and this is
would be another fruitful avenue for functional analysis of members of the LPT family. As
noted in the relevant sections of this chapter, budding yeast has been a very important system
for studies of the LPP and SPP enzymes and for the identification of animal SMSs, whereas
studies in Drosophila continue to provide the most valuable insights into LPP function
during early development. In this regard, we note that homologues of the two most
interesting and underexplored members of the LPT family, the LPR/PRG and CSS2 proteins,
are restricted to multicellular organisms, including Drosophila and Caenorhabditis elegans,
which might indicate a role in some aspect of cellular communication. Finally, as noted at
the very beginning of this article, enzymatic analysis of these enzymes necessarily involves
studies using exogenously provided substrates presented in unnatural physical forms. The
development of assay systems, for example, using fluorescent substrates as reporters, to
monitor enzyme activity in intact cells or tissues would allow researchers to evaluate LPT
activity in situ.
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CHAPTER 2
ENZYMATIC ANALYSIS OF LIPID PHOSPHATE
PHOSPHATASES
In Part Reprinted from: Methods, 39, McDermott, M. I., Sigal, Y. J., Crump, J. S. and
Morris, A. J. Enzymatic analysis of lipid phosphate phosphatases, Pages 169-79, Copyright
(2006), with permission from Elsevier
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1. ABSTRACT
Lipid phosphate monoesters including phosphatidic acid, lysophosphatidic acid,
sphingosine 1-phosphate and ceramide 1-phosphate are intermediates in phosho- and
sphingo-lipid biosynthesis and also play important roles in intra- and extra- cellular
signaling. Dephosphorylation of these lipids terminates their signaling actions and, in some
cases, generates products with additional biological activities or metabolic fates. The key
enzymes responsible for dephosphorylation of these lipid phosphate substrates are
collectively termed lipid phosphate phosphatases (LPPs). Biochemical, pharmacological,
cell biological and genetic studies identify roles for LPPs in both intracellular lipid
metabolism and the regulation of both intra- and extra- cellular signaling pathways that
control cell growth, survival and migration. This chapter describes procedures for the
expression of LPPs in insect and mammalian cells and their analysis by SDS PAGE and
western blotting. The most straightforward way to determine LPP activity is to measure
release of the substrate phosphate group. We described methods for the synthesis and
purification of [32P]-labeled LPP substrates. We describe the use of both radiolabeled and
fluorescent lipid substrates for the detection, quantitation and analysis of the enzymatic
activities of the LPPs measured using intact or broken cell preparations as the source of
enzyme.
50
2. INTRODUCTION
Monophosphate esters of phospholipids and sphingolipids are positioned at a critical
intersection between “housekeeping” pathways of cellular lipid metabolism and mechanisms
responsible for signaling both within and between cells. Phosphatidic acid (PA) and its
dephosphorylation product diacylglycerol (DG) can be formed by the actions of agonist-
stimulated inositol lipid specific phospholipases C and phosphatidylcholine specific
phospholipases D. DG is well established to be an intracellular second messenger that
regulates the activity of a number of protein targets, most prominently protein kinase C
(PKC) (Exton, 1990; Exton, 1994). PA is emerging as a regulator of pleiotropic signaling
responses that may involve activation of the mammalian target of rapamycin (mTOR), the
Raf protein kinase and phosphatidylinositol 4-phosphate 5-kinase (Chen and Fang, 2002;
Cummings et al., 2002; Ghosh et al., 1997). The monoacylated derivative of PA,
lysophosphatidic acid (LPA) is an extracellular signaling molecule that regulates cell growth,
survival and migration through actions at G-protein coupled cell surface receptors. LPA is
also a key intermediate in the de novo synthesis of PA by acylation of glycerol 3-phosphate,
and both PA and DG are precursors for the synthesis of all of the major classes of
phospholipids. Similarly ceramide 1-phosphate (C1P) and sphingosine 1-phosphate (S1P)
and their dephosphorylation products ceramide and sphingosine are important cellular
signaling molecules, and are both precursors for the synthesis of the major cellular
sphingolipid, sphingomyelin. Ceramide is an intracellular regulator of apoptosis while, like
LPA, S1P is a G-protein coupled receptor agonist with a broad range of actions (Brindley et
al., 2002).
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Lipid phosphate phosphatases (LPPs) are the major class of enzymes responsible for
the dephosphorylation of PA, LPA, C1P and S1P (Brindley, 2004; Sigal et al., 2005). These
are distinct from a widely expressed soluble Mg2+-dependent PA-specific phosphatases that
have been characterized in some detail but not yet been identified at a molecular level
(Roberts et al., 1998; Waggoner et al., 1996; Waggoner et al., 1995). Primary role of LPPs is
directly correlated to their ability to dephosphorylate small lipid phosphates (Brindley et al.,
2002; Sigal et al., 2005). Figure 2.1 shows the structures of the LPP substrates discussed
above, and their dephosphorylation products. “Ecto” phosphatase activity of these proteins is
thought to regulate cell signaling at the cell surface by converting bioactive signaling lipids,
such as LPA and S1P, to inactive lipid moieties (Jasinska et al., 1999; Roberts and Morris,
2000; Smyth et al., 2003). Intracellularly localized LPPs, meanwhile maintain a balanced
pool of cellular phospholipids and their dephosphorylated products (Alderton et al., 2001a;
Yue et al., 2004). LPPs have been also reported to mediate an uptake of dephosphorylated
lipid product from the extracellular space into the cytosol in a phosphatase dependent manner
(Renault et al., 2004; Roberts and Morris, 2000). By facilitating cellular lipid uptake, plasma
membrane localized LPPs do more then simply deactivate signaling lipids at the cell surface,
and may also indirectly regulate intracellular lipid signaling given that internalized lipids
may act as precursors for the synthesis of other intracellular signaling molecules. A study
examining the role of wunens, LPP homologues in drosophila, has revealed that proper
balance between wunens expressed on migrating germ cell and the surrounding somatic cells
is important for appropriate migration and survival of germ cells during embryo development
(Renault et al., 2004). Furthermore, this study has demonstrated that wunens can facilitate
phosphatase dependent lipid endocytosis, suggesting that regulated accumulation of lipid
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signaling molecules may be an important signaling mechanism required for proper
drosophila embryo development, especially given a lack of any G protein-coupled
lysophospholipid receptors in the drosophila genome (Hla et al., 2001; Renault et al., 2002).
Figure 2.1 Structures of LPP Substrates and Products.
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LPPs belong to a broader family of proteins, called Lipid
Phosphatase/Phosphotransferases (LPTs) (Sigal et al., 2005). These include enzymatically
inactive proteins called Lipid Phosphatase Related (LPR) proteins, one of which will be
examined in great detail in the following chapter, and two proteins called Sphingomyelin
Synthases (SMS) that act as phosphotransferases by transferring the headgroup of
phosphatidylcholine onto ceramide to generate sphingomyelin. Special techniques have been
developed to examine the enzymatic properties of these proteins (Huitema et al., 2004;
McDermott et al., 2004). In this chapter we will describe the methods used to detect,
quantitate and analyze the phosphatase, phosphotransferase and endocytotic activities of
LPTs, with a particular focus on LPPs. We will also discuss sources of endogenously
expressed LPP activities and describe methods for the recombinant expression of LPPs in
insect and mammalian cells.
3. DESCRIPTION OF METHOD
Figure 2.2A summarizes LPP catalyzed reaction using LPA as a substrate. The LPP
assays described here require a source of enzyme, substrate, a system to incubate the
substrate with the enzyme and a method for determining enzyme activity by analytical
separation of unreacted substrate from the LPP reaction products. This is most simply
accomplished by using substrates incorporating radioactive or fluorescent tracers into either
the phosphate group or fatty acid chains. LPP activity is then measured by monitoring the
production of inorganic phosphate or by using thin layer chromatography (TLC) to analyze
the reaction products.
A slight variation of the above technique may also be used to effectively elucidate
whether LPPs are also capable of achieving a phosphotransferase reaction. SMS are to date
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the only members of the LPT family that have been reported to catalyze such a reaction
(Huitema et al., 2004). However, it may be plausible to speculate that a nucleophilic attack
on the phosphate group of a phospholipid substrate during an LPP assay that is normally
mediated by water may be carried out by an alcohol group of an extraneous ceramide or
glycerol based lipid, if such a source were present, resulting in a transfer of a phosphate
group onto this lipid rather then release of inorganic phosphate (Figures 1.4 and 2.2B).
Figure 2.2 Phosphatase (A) and Phosphotransferase (B) Reactions and Assay
Strategies.
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To assess this activity a TLC approach may be used as illustrated in Figure 2.2B. Upon
completion of an LPP assay the organic phase is removed and is separated by TLC to
determine whether, if any, new phospholipids are formed, which can be identified by the
presence of lipid standards. This section provides a conceptual overview of the requirements
associated with these techniques. The following sections contain details of reagents and
experimental equipment required, and instructions for their use in measurements of LPP
activity.
3.1 Endogenous sources of LPP activity
RNA analysis, substantiated to a lesser extent by western blotting studies, indicate
that LPP1, 2 and 3 are widely expressed in mammalian cells and tissues (Kai et al., 1996; Kai
et al., 1997; Sciorra and Morris, 1999; Sigal et al., 2005). Consistent with these observations,
LPP activity has been detected in lysates or resolved membrane preparations from essentially
all mammalian cells and tissues examined (Brindley et al., 2002; Sigal et al., 2005). LPPs
are localized to the surface of many cells, so LPP activity can also be measured using intact
cells as a source of enzyme (Ishikawa et al., 2000; Jasinska et al., 1999; McDermott et al.,
2004; Roberts et al., 1998; Roberts and Morris, 2000; Tanyi et al., 2003). The use of
membrane preparations rather than whole cell lysates as a source of enzyme can also result in
significant enrichment of LPP activity and consequently minimizes interference from
competing phosphatases, notably the soluble PA phosphatase activity noted in the
introduction.
3.2 Recombinant expression of LPPs in mammalian and insect cells
Recombinant expression can be used to examine the catalytic properties of specific
LPP isoforms. Discrimination of endogenous LPP activities from those of exogenously
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expressed LPPs is an important consideration in selecting cell systems for recombinant
expression and analysis of these enzymes. Transient or stable overexpression of LPPs 1-3
can be accomplished using conventional expression vectors with retroviral promoters.
Vectors employing the cytomegalovirus promoter are particularly effective for expression of
LPPs in a wide range of mammalian cell types (Jasinska et al., 1999; McDermott et al., 2004;
Roberts and Morris, 2000; Sciorra and Morris, 1999). We and others have also used
recombinant retroviruses or adenovirus vectors for this purpose (Zhao et al., 2005). These
proteins are tolerant of epitope tagging at either the N- or C- termini with small sequence
epitopes such as the haemophillus influenza virus (HA) tag or the myc epitope (Kai et al.,
1996; Kai et al., 1997; McDermott et al., 2004; Roberts et al., 1998; Sciorra and Morris,
1999). C-terminal fusions of these proteins with green fluorescent protein (GFP) are also
effectively expressed and are enzymatically active (Jasinska et al., 1999; McDermott et al.,
2004; Roberts et al., 1998). Although N-terminally tagged LPPs are expressed and are
enzymatically active, localization studies indicate that they are retained in the endoplasmic
reticulum and do not traffic to the plasma membrane as is often observed with the C-
terminally tagged variants, suggesting that a role for the N-terminus in intracellular sorting of
the proteins is compromised by modification of this region of the proteins (unpublished
observations). Because LPPs are widely expressed, endogenous LPP activity is readily
detectable in most mammalian cell lines. Consequently, even at transfection efficiencies in
excess of 50%, increases in LPP activity observed in these experiments are generally modest
(in the range of 1.5-2-fold). HEK293 cells are particularly effective for recombinant
expression and enzymatic analysis of LPPs (Figure 2.3) because they contain relatively low
endogenous levels of LPP activity, and overexpression of LPPs results in 5-7 fold increases
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in LPP activity, so we have used this cell type extensively for transient and stable
overexpression of LPPs (McDermott et al., 2004; Roberts et al., 1998; Roberts and Morris,
2000).
Figure 2.3 Expression of LPP3 in HEK293 cells. A. LPP3 was overexpressed by transient
transfection of HEK293 cells. Samples from vector (pcDNA) and pcDNA-LPP3 transfected cells
were examined by SDS PAGE and western blotting using an LPP3- selective antibody. Unlike
HEK293 cells, Swiss 3T3 cells express readily detectable levels of LPP3 and a sample from these
cells was used as a positive control. The two major immunoreactive LPP3 species represent mature
glycosylated and non-glycosylated forms of the protein (Sciorra and Morris, 1999) B. Determination
of LPP activity in membrane fractions prepared from HEK293 cells transfected with vector (pcDNA)
or pcDNA-LPP3, using Triton X-100 micelles and [32P] labeled substrate.
For more detailed studies, the endogenous levels of LPP activity in mammalian cells
impedes enzymatic characterization of recombinantly expressed LPPs. We have therefore
also developed baculovirus vectors for recombinant expression of LPPs in cultured insect
58
cells (Figure 2.4). Infection of insect cells with these vectors results in 500-1000 fold
increases in membrane-associated LPP activity (Roberts et al., 1998). Expression of a his6
tagged variant of LPP1 in these cells facilitates partial purification of the protein for use in
reconstitution studies (Roberts and Morris, 2000).
Figure 2.4 Kinetic analysis of LPP1 Expressed in Sf9 Cells. A. LPP1 or an irrelevant control
protein was expressed in Sf9 cells using recombinant baculovirus vectors. Proteins were examined by
SDS PAGE and western blotting using an LPP1 specific antibody. The lower immunoreactive
species (~28KDa) likely represent unglycosylated or core glycosylated forms of the protein which the
higher (~33 KDa) species are likely to correspond to mature glycosylated forms of the protein (Smyth
et al., 2003). The “smear” of immunoreactive material at the top of the gel is characteristic of what
we presume to be aggregated forms of the protein that are commonly seen when LPPs are examined
by SDS PAGE and western blotting. B. Detergent extracts from membrane fractions of LPP1
expressing Sf9 cells were used as a source of activity for a kinetic analysis of the activity of LPP1
against PA () and LPA (). Initial rates of LPP1 activity were determined when the mole fraction
of substrate in mixed micelles of substrate and Triton X-100 was varied as indicated (Roberts et al.,
1998).
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Expression of recombinant LPPs can be monitored by western blotting using
antibodies against appended epitope tags or antibodies raised against unique peptide epitopes
that are specific for particular LPP isoforms which have been described by ourselves and
others (McDermott et al., 2004; Sciorra and Morris, 1999; Smyth et al., 2003; Zhao et al.,
2005)
3.3 Radiolabeled and fluorescently labeled substrates
When studied using in vitro assays, the three mammalian LPP enzymes, LPP1, LPP2
and LPP3 exhibit relatively broad specificity for hydrolyses of PA, LPA, C1P and S1P
(Roberts et al., 1998; Waggoner et al., 1996; Waggoner et al., 1995). Measurement of LPP
activity can, therefore, be most simply accomplished by incubating preparations of the
enzyme with lipid substrates containing a radioactive phosphate group and monitoring the
formation of radioactive inorganic phosphate. Sensitivity of this radiochemical assay is
effectively limited only by the specific radioactivity of the substrate employed, so detection
levels in the pmol range (which are more than adequate for characterization of endogenous
LPP activities) are readily attainable. If enzyme activities are higher, as is often the case with
recombinantly expressed activities, and care is taken to exclude contaminating inorganic
phosphate from the enzyme and substrate preparations, LPP activity can also be quantitated
using unlabeled substrates and detection of released inorganic phosphate using standard
colorimetric or enzyme linked assays which are sensitive in the nmol range (Walsh and Bell,
1992). Substrates containing radiolabeled acyl chains are also available commercially. LPPs
are highly tolerant of modifications to the acyl chains of their substrates and readily
hydrolyze lipid substrates containing fluorescent groups appended to one or both of their acyl
chains (Roberts and Morris, 2000; Sciorra and Morris, 1999). Although assays using acyl
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chain labeled or fluorescently labeled substrates are more time consuming than the
“phosphate release” assays noted above, because they require chromatographic separation of
unreacted substrate from reaction product, they have proved particularly useful for
monitoring LPP activity in intact cells where LPP-catalyzed substrate hydrolysis is linked to
the intracellular accumulation of lipid hydrolysis products (Renault et al., 2004; Roberts and
Morris, 2000).
3.3.1 Preparation of [32P]-labeled LPA, PA and C1P using bacterial
diacylglycerol kinase- [32P]-labeled LPA, PA and C1P can be prepared using bacterial
diacylglycerol kinase and -[32P]-ATP to phosphorylate monoacylglycerol, diacylglycerol or
ceramide respectively (Walsh and Bell, 1992). Substrates are solubilized with detergent in
the presence of cardiolipin which stimulates the kinase activity of the enzyme. Reactions are
terminated using acidified organic solvents and substrates are purified by anion exchange
HPLC to remove any contaminating -[32P]-ATP, unreacted substrate, detergent and
cardiolipin. For some analyses, particularly those in which the disposition and fate of the
lipid product of the LPP catalyzed reaction is to be studied, the use of substrates with
radioactive label in the acyl chains is preferred. [3H] LPA and PA are commercially
available, or can be simply prepared by phosphorylation of commercially available [3H]-
labeled MAG or DG using diacylglycerol kinase as described above. Lipids produced by
diacylglycerol kinase are purified by HPLC employing a minor modification of a procedure
we have described elsewhere for the purification of radiolabeled and unlabeled
phosphoinsitides (Du et al., 2002).
3.3.2. Preparation of [32P]-S1P- [32P]-S1P can be made by deacylation of [32P]-C1P
which is prepared as noted in the preceding section and purified by TLC (Jamal et al., 1991).
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3.3.3 Fluorescent lipid substrates- Fluorescent lipid substrates offer a number of
advantages for LPP assays. They are commercially available in several forms, highly stable
during storage and, when coupled with fluorescent detection of reaction products, offer a
specific and sensitive way to monitor LPP activity. 6-(7-nitro-2-1,3-benzoxadiazol-4-
yl)amino (NBD) labeled PA and S1P are available from Avanti Polar Lipids. In both cases,
the lipids are available with 6- or 12- carbon “spacers” linking the NBD groups to the lipid
backbone. Molecular Probes Inc manufacture pyrene and 4,4-difluoro-5,7-dimethyl-4- bora-
3a,4a-diaza-s-indacene (BODIPY) labeled PA. LPPs are highly tolerant of these
modifications to the substrate acyl chain, and we do not observe significant differences in
activity against these fluorescent substrates in comparison to their non-fluorescent
counterparts. The superior fluorescence characteristics of the BODIPY labeled lipids in
comparison to those labeled with NBD make them particularly suitable for analyzing LPP
activity by measuring the accumulation of fluorescent lipid deacylation products in live cells
(Renault et al., 2004; Roberts and Morris, 2000).
3.4 Determination of LPP activity
By definition, LPPs catalyze the water-dependent hydrolysis of the monoester
phosphate group of their lipid substrates forming stoichiometric quantities of inorganic
phosphate (Pi) and a lipid dephosphorylation product containing a free hydroxyl group.
Measurement of LPP activity can therefore be simply accomplished by monitoring the
formation of either product after using a suitable fractionation method to resolve product
from unreacted substrate. Direct measurement of the release of Pi is the simplest way to
detect and quantitate LPP activity because it is straightforward to separate water soluble
phosphate from unreacted lipid substrate. These assays are simplest using substrates labeled
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with [32P]-PO42- (McDermott et al., 2004; Roberts et al., 1998; Sciorra and Morris, 1999;
Sigal et al., 2007; Waggoner et al., 1996) although it is also possible to detect phosphate
released from unlabeled substrates by colorimetric or coupled enzymatic assays (Luquain et
al., 2003b). Assays in which LPP activity is determined by following the production of
radiolabeled or fluorescent lipid products generated by hydrolysis of an appropriate substrate
are necessarily more time consuming because they require a chromatographic step to separate
substrate from product. Interpretation of data obtained from these kinds of assays can be
complicated because the lipid products of the LPP catalyzed reaction can be further
metabolized. In contrast to many other phosphatases, LPP activity is characteristically
independent of divalent metal ions (Waggoner et al., 1996). In assays using crude enzyme
preparations or where LPP activities are low, inclusion of EDTA in the assay system inhibits
competing phosphatase activities.
3.5 Substrate presentation
Like many other lipid metabolizing enzymes, LPP activity is critically dependent on
the physical form and composition of the substrate preparation. LPPs are particularly active
against substrates dispersed in non-ionic detergents, most notably Triton X-100, which can
be used with broken cell membrane preparations or detergent extracted proteins as the source
of enzyme (Roberts et al., 1998; Sciorra and Morris, 1999; Waggoner et al., 1996; Waggoner
et al., 1995). In assays using intact cells where detergents cannot be employed, LPP activity
can be studied using protein bound substrates (Jasinska et al., 1999; McDermott et al., 2004;
Roberts et al., 1998; Roberts and Morris, 2000).
3.5.1 Mixed micelle assay using Triton X-100- Mixed micelles of LPP substrates
and Triton X-100 have been widely used to analyze LPP activity from a range of sources
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(Lin and Carman, 1990; Roberts et al., 1998; Waggoner et al., 1996). When acting on
detergent solubilized substrates, LPP activity exhibits surface dilution kinetics in which the
rate of substrate hydrolysis depends on the molar fraction of substrate in the mixed detergent
and lipid micelle. There are modest differences in substrate affinity (interfacial Km) and Vmax
observed when LPPs 1-3 are incubated with phospho- and sphingo- lipid substrates presented
in this manner (Roberts et al., 1998). This assay system has also been used to identify and
characterize hydrolysis-resistant analogs of PA as effective competitive inhibitors of LPP
activity (Smyth et al., 2003).
3.5.2 Competitive inhibitors of LPP activity. The activity of LPPs, unlike that of
soluble Mg2+-dependent PA phosphatases, are insensitive to inhibition by the alkylating
agent N-ethyl maleimide (Roberts et al., 1998; Waggoner et al., 1996; Waggoner et al.,
1995). Propranolol is a moderately effective inhibitor of LPP activity (Roberts et al., 1998),
while we recently observed that a phosphothionate analog of LPA that has, by virtue of its
resistance to LPP activity, been employed as a metabolically stable LPA receptor agonist was
an effective LPP inhibitor (Tanyi et al., 2003). These findings prompted researchers to look
for new compounds that inhibited LPA dephosphorylation without directly stimulating LPA
signaling because of their obvious potential as tools to probe LPP function. Recently
synthesized fluorinated analogs of LPA and PA (Xu and Prestwich, 2002a; Xu and
Prestwich, 2002b), the structure of which is shown in Figure 2.5A, are good candidates as
potential inhibitors of LPP activity. XY-3 and -4 are analogs of 2-oleoyl- and 2-palmitoyl-
LPA with a difluoromethyl group at the sn-1 position but an unmodified phosphomonoester
group. Compounds XY-13 and -14 are a pair of enantiomeric analogs of dioleoyl-PA with a
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phosphatase-resistant difluoromethylenephosphonate group replacing the sn-3 phosphate
group.
3.5.3 Intact cell LPP assays- LPPs are also active against substrates presented as
protein bound aggregates, notably complexed with fatty acid free BSA. LPPs localize to the
plasma membrane in many cell types where they are responsible for “ecto” lipid phosphatase
activity that terminates the receptor-directed signaling actions of LPA and S1P. BSA bound
substrates are particularly appropriate for analysis of LPP activity in intact cell preparations
where detergent solubilized substrates cannot be used (McDermott et al., 2004; Roberts et al.,
1998; Roberts and Morris, 2000). As discussed further in the next section, in these kinds of
assays there is considerable cellular accumulation of the lipid dephosphorylation products of
the LPP reaction, so complete analysis of reaction products requires analysis of both the
culture medium and cell-associated lipids.
3.5.4 Measurement of LPP-promoted lipid uptake in intact cells. Overexpression
of LPPs in insect or mammalian cells promotes the intracellular accumulation of lipid
dephosphorylation products (McDermott et al., 2004; Renault et al., 2004; Roberts and
Morris, 2000). This process can be readily studied using fluorescent lipid substrates, for
example the NBD- or BODIPY- derivatives of PA and LPA as noted above. Although this
phenomenon can be observed using BSA bound substrates, we find that mixed phospholipid
vesicles composed of palmitoyl oleoyl phosphatidylcholine (POPC) containing low molar
fractions of LPP substrates are often a more effective substrate preparation for these assays
(Roberts and Morris, 2000). This is possibly because vesicular substrates partition more
effectively into the outer leaflet of the plasma membrane of cells than protein bound
substrates. Rhodamine labeled phosphatidylethanolamine (Rh-PE) can be included in these
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assays to provide a substrate independent means to detect and quantitate these vesicles and
monitor non-specific lipid uptake by the cells. Accumulated lipids can be visualized by
fluorescence microscopy in either live or fixed cells or extracted from the cells for analysis
by TLC (Renault et al., 2004; Roberts and Morris, 2000).
4. MATERIALS AND EQUIPMENT
4.1 General reagents, equipment and supplies
Sources of general reagents used in the procedures described in this article can be
found in primary research articles from our laboratory (Escalante-Alcalde et al., 2003;
McDermott et al., 2004; Renault et al., 2004; Sciorra and Morris, 1999; Smyth et al., 2003;
Tanyi et al., 2003). Sources of specific reagents and those not generally found in a well-
equipped biomedical research laboratory are listed here. E. coli diacylglycerol kinase for the
preparation of [32P] labeled LPP substrates is obtained from Calbiochem and reconstituted at
1mg/ml (Specific activity: > 2 units/mg protein. One unit is defined as the amount of enzyme
that will phosphorylate 1.0 mmol of DAG per minute at 25°C, pH 6.6). -[32P]-ATP can be
purchased from ICN/MP Biomedicals. End labeling grade (specific radioactivity 6000
Ci/mmol) is suitable for this purpose. For assays in which lipid substrates are complexed
with BSA it is important to use fatty acid free BSA (fatty acid content <0.005%) which is
available from Sigma Aldrich (St Louis, MO). Triton X-100 and -D-octyl glucoside
detergents used for LPP assays and the preparation of LPP substrates are available from
Pierce Biotechnology, Rockford IL.
In general, the procedures described require standard equipment that is likely to be
available in a well-equipped biochemical laboratory (water baths, medium speed centrifuges/
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microcentrifuges). The preparation of radiolabeled LPP substrates and the analysis of
reaction products in assays using LPP substrates with radiolabeled or fluorescently labeled
acyl chains requires the removal of volatile organic solvents from lipid containing material
which can be most simply accomplished using a “speed-vac” type centrifugal concentrator
equipped with an appropriate solvent trap. To analyze LPP mediated lipid uptake, a
microscope equipped with a filter set to visualize NBD or BODIPY is required. If such filter
is not present a simple GFP or FITC filter set will suffice. If Rh-PE is included in the lipid
uptake assays, rhodamine, or other suitable filter set is needed to visualize this lipid.
4.2 Mammalian and insect cell culture and preparation of cell lysates and membrane
fractions
HEK293 cells are used for overexpression of LPPs with plasmid vectors.
Transfections use lipofectamine reagent (Invitrogen Inc, Carlsbad, CA). Insect cells (most
commonly Sf9 cells) are used for overexpression of LPPs using baculovirus vectors. Both
cell types are available from ATCC. Culture and transfection/infection of these cells follows
standard procedures.
4.3 Unlabeled, radiolabeled, unhydrolyzable and fluorescently labeled lipids
Unlabeled PA, LPA, C1P, PC and S1P in various acyl chain configurations are
available from Avanti Polar Lipids (Alabaster AL). C1P and S1P are also available from
BioMol Inc (Plymouth Meeting, PA). 6-(7-nitro-2-1,3-benzoxadiazol-4-yl)amino (NBD)
labeled PA and S1P are available from Avanti Polar Lipids. 2-(4,4-difluoro-5,7-dimethyl-4-
bora-3a,4a-diaza-s-indacene-3-pentanoyl) (BODIPY) labeled PA is available from Molecular
Probes Inc (Eugene OR). Mono- and diacyl- glycerols with a variety of acyl chain
compositions for the preparation of radiolabeled LPA and PA are available from Nu-Chek-
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Prep (Elysian, MN). The lipids are stored at -20 °C as 1-10 mg/ml solutions in CHCl3. [3H]-
mono- and diacylglycerols can be obtained from American Radiolabeled Chemicals Inc (St
Louis, MO). Lissamine™ Rhodamine B Sulfonyl (Rhodamine) labeled
phosphatidylethanolamine (PE) is available from Avanti Polar Lipids (Alabaster, AL). (3S)
[1,1-difluoro-3,4-bis (oleoyloxy) butyl] phosphonate (XY-14) can be purchased from
Echelon Biosciences Inc (Salt Lake City, UT).
4.4 HPLC equipment and solvents
Purification of radiolabeled lipids requires a gradient forming HPLC system equipped
with a 1.0-5.0 ml loading loop and a fraction collector. An in-line radioactivity detector
makes identification of the labeled products easier. A liquid scintillation counter is required
for quantitation of the purified lipid products. Lipids are separated by anion exchange HPLC
using an Econosil NH2 5µ column (250 x 4.6 mm) (Alltech Inc). The solvent system used
consists of solvent A: 20:9:1 CHCl3:MeOH:H2O. Solvent B: Solvent A containing 1 M
ammonium acetate.
4.5 Thin layer chromatography equipment and solvents
Thin layer chromatography (TLC) is used to separate LPP substrates and products in
assays using substrates with radiolabeled or fluorescently labeled acyl chains.
Glass TLC tank lined with Whatman Chromatography paper, 20 X 20 cm Merk 60A
silica glass TLC plates without fluorescent indicator, Spotting solution: 1:1 CHCl3:MeOH.
Solvent system for purification of [32P] S1P: (3:1:1 butanol: acetic acid: H2O).
Solvent system for analysis of radiolabeled or fluorescently labeled LPP substrates
and products: 38:9:4.5 CHCl3:MeOH:acetic acid.
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4.6 Assay buffers and other solutions
4.6.1 5X Diacylglycerol kinase assay Buffer- 250 mM Imidazole, pH 6.6, 250 mM
NaCl, 62.5 mM MgCl2), 5 mM EGTA, 100 mM DTT.
4.6.2 Other solutions for diacylglycerol kinase reactions- Lipid substrates (see
above), 10% -D-octylglucoside, 10 mg/ml Cardiolipin in CHCl3, synthetic upper and lower
phases made by combining CHCl3, MeOH and 0.1M HCl in the ratio 1:1:0.9 v/v in a
separating funnel.
4.6.3 Solvents for extraction of purified LPP substrates from HPLC column
fractions- 3M HCl, CHCl3 , synthetic upper and lower phases (see above).
4.6.4 Deacylation reagent for preparation of [32P]-S1P from [32P]C1P- 6M
HCl:butanol 1:1 (v/v).
4.6.5 5X LPP assay buffer for Triton X-100 mixed micelle LPP assay-
100mM Tris, pH 7.5 mM EGTA, and 10 mM EDTA.
4.6.6 Stop solutions for Triton X-100 mixed micelle LPP assay- 10 mg/ml BSA,
10% Tricholoroacetic acid.
4.6.7 Stop solutions for assays using substrates with radiolabeled or fluorescently
labeled acyl chains- 40:80:1 CHCl3:MeOH: concHCl, CHCl3, 0.1M HCl
4.6.8 Solutions for intact cell LPP assays- Appropriate cell culture medium
(without serum and antibiotics). 10mg/ml fatty acid free BSA.
4.6.9 Lysis buffer and SDS PAGE loading buffer- Lysis buffer: 10 mM Tris HCl
pH 7.4, 1 mM EDTA pH 8.0 containing 1mM phenylmethyl sulphonyl fluoride and 2 mM
Benzamidine. 4x SDS PAGE loading buffer: 200 mM Tris HCl pH 6.8, 400 mM DTT,
8% SDS, 0.4% Bromophenol blue, 20% glycerol.
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5. INSTRUCTIONS
5.1 Preparation of [32P]-PA, LPA and C1P using bacterial diacylglycerol kinase
5.1.1 Kinase reactions- 75 µl 10 mg/ml cardiolipin and 1 µMol substrate
(monoacylglycerol, diacylglycerol or ceramide) are combined in a 15 ml polypropylene tube.
The solvent is removed by evaporation. The dried lipids are resuspended in 37.5 µl 10%
octylglucoside by vortexing. 100 µl 5 X diacylglycerol kinase assay buffer (4.6.1), 10 µl 100
mM DTT and water are added to a final volume of 480 µl. The contents are extensively
mixed by vortexing and, if necessary, the tube can be warmed in a 37 °C water bath to
dissolve lipids completely. Reactions are started by adding 10 µl diacylglycerol kinase and
-[32P] ATP (0.1-1 mCi) and water if needed to a final volume of 500 µl. Reactions are
incubated at 25 °C in a shaking waterbath for 3-12 hours.
5.1.2. Reaction termination and product extraction- The kinase reaction is
terminated by adding 0.5 ml 0.1 M HCl to give a final volume of 1 ml. 3.75 ml of 40:80:1
CHCl3:MeOH:concHCl is then added and the contents mixed to give a single phase. A
further 1.25 ml of CHCl3 and 1.25 ml of 0.1 M HCl are then added. The contents are mixed
by vortexing and gently centrifuging (100xg in a swinging bucket centrifuge) to separate the
aqueous and organic phases. The upper (aqueous) phase is removed and discarded. The
lower (organic) phase is washed twice with synthetic upper phase. The washed lower phase
is removed to a new 15 ml polypropylene tube and evaporated to dryness.
5.1.3 Product purification by HPLC- The dried lipids extracted from the
diacylglycerol kinase reaction, are dissolved in 0.5-1.0 ml of CHCl3:MeOH:H2O (20:9:1-
HPLC solvent A) and injected onto an Econosil NH2 HPLC column. The column is eluted
with a 200 ml linear gradient of 0-1M ammonium acetate in solvent A at a flow rate of 2
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ml/min. The eluant is collected as 4ml fractions and the desired products are identified by
on-line monitoring of eluant radioactivity or by liquid scintillation counting of small aliquots
of each fraction. With a new column, LPA, PA and C1P are recovered in fractions 45-55
under these conditions. Fractions containing the products are pooled and the lipids extracted
by the addition of 3M HCl and CHCl3 (Du et al., 2002) followed by vortexing and
centrifugation to separate the phases, removal of the upper phase and thorough washing of
the lower phase with synthetic upper phase as described. The pooled lower phases are
evaporated to dryness and then resuspended in a small volume of CHCl3 for storage at -20°C.
5.1.4. Notes and tips for troubleshooting- Yields (measured as incorporation of -
[32P]-ATP radioactivity into lipid product) using this procedure are generally in the range of
50-70 %. Diacylglycerol kinase activity against ceramide is somewhat lower than observed
with mono- or diacylglycerol so yields of C1P obtained using this procedure are generally
lower than those of LPA and PA. After purification by HPLC, thorough extraction of
ammonium acetate from the purified products is important because contaminating
ammonium ions can promote base-catalyzed deacylation of the lipids leading to a slow
accumulation of water soluble radioactivity over time. Substrates prepared in this manner are
stable for weeks when stored in CHCl3 solution at -20 °C. Some preparations of CHCl3,
particularly those marked as “anhydrous” can be strongly acidic and are therefore unsuitable
for use in the HPLC procedure. Diacylglycerol kinase can also be used to prepare LPA and
PA with [3H]-labeled acyl chains using commercially available [3H]-mono and diacyl-
glycerols as substrates. In this case, the reactions include 10 mM unlabeled ATP in place of
the -[32P]-ATP although a trace amount of -[32P]-ATP can be included to monitor the
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reaction and simplify detection of the product by online monitoring of the HPLC eluant or
TLC and autoradiography.
5.2 Preparation of [32P]-S1P
5.2.1. Preparation of sphingosine 1-phosphate- [32P]-C1P prepared as described
above (generally 10-100 µCi) in CHCl3 solution is evaporated to dryness and dissolved in 0.5
ml of 6M HCl/n-butanol 1:1 v/v and heated at 100 °C for one hour in a sealed glass tube.
After cooling on ice, the sample is evaporated to dryness, resuspended in 10-20 µl of 1:1
CHCl3:MeOH and then spotted onto a TLC plate which is developed in a paper-lined tank
with a solvent system of 3:1:1 n-butanol:acetic acid: water to purify the S1P product (Rf
~0.35) (Waggoner et al., 1996).
5.2.2. Notes and tips for troubleshooting. [32P]-S1P can also be prepared by
phosphorylation of sphingosine catalyzed by sphingosine kinase. Unfractionated cytosol
from several fibroblast cell lines (e.g. Swiss 3T3 fibroblasts) is an effective source of the
enzyme (Edsall et al., 2000).
5.3 Preparation of membrane fractions from cultured cells
Adherent cells grown in 35 mm diameter dishes (~2-5 x 104 cells) are collected by
scraping in 1 ml of culture medium, transferred to a 1.5 ml microcentrifuge tube and
recovered by centrifugation at 4000 rpm at room temperature in a microfuge. An equivalent
number of cells grown in suspension can be harvested by centrifugation. The cell pellet
(which can be washed once in ice-cold phosphate buffered saline if needed to remove
residual culture medium) is resuspended in 500µl of ice cold lysis buffer (4.6.9) and the cells
are disrupted by probe sonication (3 bursts of 3 seconds, on ice). A total particulate fraction
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is recovered from the lysate by centrifugation at 30,000 x g at 4 °C and resuspended in 100-
200 µl of lysis buffer.
5.4 Expression of LPPs in HEK293 Cells
Cells are grown in 35 mm diameter dishes, seeded at 2.5 x 104 cells/dish 12 hours
prior to transfection. Each dish of cells is transfected with 1.5 µg of purified plasmid DNA
using Lipofectamine and Lipofectamine plus reagent (Invitrogen Inc). After 24-48 hours, the
cells are harvested and membrane fractions prepared as described in section 5.3.
5.5 Expression of LPPs in insect cells using baculovirus vectors
Sf9 cells are grown in monolayer cultures and infected with recombinant
baculoviruses for expression of LPPs as described (Roberts et al., 1998). After 24-48 hours
the cells are harvested and membrane fractions prepared using the procedure described in
section 5.3 but on a larger scale. For example, a 75 cm2 flask of sf9 cells containing ~5 x 106
cells would be resuspended in 5mls of lysis buffer before disruption by sonication.
5.6 Analysis of LPPs by SDS PAGE
Expression of endogenous or recombinantly expressed LPPs is monitored by SDS
PAGE and western blotting using standard procedures. We have observed that, as is often
the case with strongly hydrophobic membrane proteins, boiling of samples prior to SDS
PAGE often results in significant aggregation of the LPPs such that the immunoreactive
proteins will not enter the resolving gel. Samples are therefore incubated in SDS PAGE
loading buffer (4.6.9) at room temperature before gel loading. Recombinantly expressed
LPPs can be detected by western blotting using antibodies against appended N- or C-terminal
tags. Selective anti-peptide antibodies that are effective for detection of LPP1 and LPP3
have also been described (Sciorra and Morris, 1999; Smyth et al., 2003).
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5.7 Determination of LPP activity using Triton X-100 micelles and [32P]-labeled
substrates
5.7.1 Substrate Preparation- The standard LPP assay described below has a total
volume of 100 µl containing a final substrate concentration of 100 µM (i.e. 10 nmol of
substrate/assay) and a Triton X-100 concentration of 3.2 mM. The detergent solubilized
substrate preparation is made at 2 X final concentration. Radiolabeled and unlabeled lipid
substrates in CHCl3 solution are combined in a polypropylene tube in sufficient quantities to
give final concentrations in the assay of 100 µM substrate containing 5,000-50,000 dpm of
radiolabeled substrate per assay. For substrates prepared using bacterial diacylglycerol
kinase as described above, the chemical concentration of the radiolabeled substrate is
negligible and can be discounted when determining how much unlabeled substrate to include.
For example, when making enough substrate for 50 assays one would combine 500 nmol of
unlabeled substrate with 2.5 x 105-2.5 x 106 dpm of radiolabeled substrate. After removal of
the solvent, the lipids would be resuspended in 2.5 ml of 6.4 mM Triton X-100.
Unhydrolizable lipid analogues, such as XY-14, may be included in the substrate preparation
step to analyze their inhibitory effects on LPP activity. Concentration of the inhibitor may
vary from assay to assay, or concentration of hydrolizable substrate, such as LPA, may vary
in a presence of a constant concentration of the inhibitor to determine the kinetics of LPPs in
the presence of this compound using Michaelis-Menten equation.
5.7.2. Incubations- For each assay, 20 µl of 5 X LPP assay buffer (4.6.5) is
combined with the source of LPP activity (for example, membranes from LPP expressing
cells prepared as described above) to a total volume of 50µl. Assays are initiated by adding
50 µl of Triton X-100 solubilized substrate to give a final assay volume of 100 µl. After
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mixing, reactions are incubated at 37° C in a water bath for times ranging from 5 minutes to
one hour. These assays are most conveniently performed in microcentrifuge tubes.
5.7.3. Assay termination and product analysis- Assays are terminated by placing
the tubes on ice and addition of 100 µl of ice cold 10 mg/ml BSA and 200 µl 10%
trichloroacetic acid to each tube. After vortex mixing, the tubes are spun in a
microcentrifuge at ~13,000 x g to sediment the insoluble BSA precipitate that forms carrying
unreacted lipid into the pellet. Released PO42- is quantitated in the supernatant by liquid
scintillation counting.
5.7.4 Notes and tips for troubleshooting- At final concentrations of 100 µM
substrate and 3.2 mM Triton X-100, the surface concentration of substrate in the mixed
substrate and Triton X-100 micelles is ~20X above the experimentally determined interfacial
Km of LPPs 1-3 for their substrates (Roberts et al., 1998). However, for reasons of substrate
accessibility and also perhaps due to effects of substrate consumption on the organization of
the detergent and substrate containing micelles, LPP activity in these assays is only linear up
to ~20% substrate hydrolysis. For experiments where precise quantitation of LPP activity is
important, care should be taken to measure initial reaction rates. Because deacylation of LPP
substrates by contaminating activities could, in theory, generate water soluble radiolabeled
reaction products other than inorganic phosphate, assay validation requires that the
radiolabeled product is definitively identified as PO42- which can be most simply
accomplished by extraction with ammonium molybdate (Roberts et al., 1998). In our
experience, in assays of endogenously expressed or recombinant LPPs in mammalian or
insect cells, the contribution of these reaction products to the water soluble radioactivity
released in these assays is negligible. This assay procedure can be simply adapted to use
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unlabeled substrates. In this case, the released PO42- can be detected using standard assay
procedures with sensitivity in the nmol range. Highly sensitive detection of released PO42- 
with a lower detection limit of 10-50 pmol can be accomplished using the PiPer phosphate
assay from Molecular Probes. In this case, LPP assays are terminated by boiling before
removal of an aliquot for PO42- determination (Luquain et al., 2003b).
Unhydrolizable PA analogues, such as XY-13 and XY-14, exhibit significant
inhibition of LPP activity when measured by the method described above (Figure 2.5B).
Increasing concentrations of XY-14 produces a marked decrease in LPP activity (Figure
2.5C). Analyses of XY-14 kinetics using Michaelis-Menten equation has revealed that XY-
14 is acting as a pure competitive inhibitor of LPP1 activity, because inhibition was
accompanied by an increase in apparent Km without changing the apparent Vmax of the
enzyme (Smyth et al., 2003). XY-14 may also be used as a potent inhibitor of LPP activity
in intact cell phosphatase assays (Figure 2.5D) (see 5.9 for assay description).
5.8 Determination of LPP activity using Triton X-100 micelles and substrates with
radiolabeled or fluorescently labeled acyl chains
5.8.1 Substrate Preparation- Substrates are prepared exactly as described (5.7.1)
except that NBD or BODIPY labeled fluorescent lipids or lipids with radiolabeled acyl
chains are substituted for the [32P]-labeled lipids. Dual labeled lipids may also be prepared
by phosphorylating [3H] MAG in the presence of -[32P] ATP to examine the
phosphotransferase activities of LPPs. For studies using radiolabeled substrates ~20-50x 103
dpm of substrate is included in each assay. For studies using fluorescently labeled substrates
0.5-1 nmol of fluorescent substrate is included in each assay. In either case, mixed micelles
of substrate, Triton X-100 and a source of enzyme are incubated as described in 5.7.2.
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Figure 2.5 Inhibition of LPP1 Activity by PA and LPA Analogs (Smyth et al., 2003). A.
Structures of unhydrolyzable PA and LPA analogs. B. Phosphatase activity of LPP1 in detergent
extracts of membranes from baculovirus-infected sf9 cells was determined using LPA substrate
presented as a component of mixed micelles of Triton X-100 at mol% values of 10, 1, and 0.1. The
concentration of XY-3, -4, -13, and -14 was 10 µM. The activities shown are initial rates of substrate
dephosphorylation expressed as a percentage of the rate of dephosphorylation observed in the absence
of any inhibitor. C. Using detergent extracts from baculovirus-infected insect cell membranes as a
source of enzyme, LPP1 activity was determined as the mol fraction of substrate in the mixed
substrate, and Triton X-100 micelles were varied in the presence of increasing concentrations of XY-
14. D. Intact platelets were preincubated in Tyrode's solution containing 0.1 mg/ml BSA with ( ) or
without (•), 10 µM XY-14 for 5 min before addition of 1 µM [32P]LPA. Dephosphorylation was
determined as described in the text. Figure reprinted from J Biol Chem 278, 43214-23.
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5.8.2 Assay termination and analysis of reaction products by TLC- Assays are
terminated by addition of 375 µl 200:400:5 CHCl3:MeOH:concHCl followed by 125 µl of
CHCl3 and 125 µl of 0.1 M HCl. After mixing and centrifugation, the lower phase is
carefully removed to a fresh tube using a Pasteur or positive displacement pipette taking care
to avoid contamination by denatured protein at the interface. Upper phase should contain the
released inorganic phosphate, and may be subjected to scintillation counting if the substrate
contained [32P]. Lower phase is evaporated to dryness and resuspended in 10 µl of 1:1
CHCl3:MeOH. Samples are spotted onto TLC plates and developed using solutions
described in 4.5. Lipids are identified by co-chromatography with authentic standards which
can be detected by staining with iodine vapor. Fluorescently labeled lipids can be visualized
and quantitated by analysis using a scanning fluorimeter. Radiolabeled lipids can be
analyzed by autoradiography or fluorography and quantitated by liquid scintillation counting
after excision from the plate as described for fluorescently labeled lipids.
5.8.3 Notes and tips for troubleshooting- For more precise quantitation of
fluorescent lipid species, after identification by fluorescence scanning, the silica coating of
the plate containing fluorescent or radioactive lipids can be scraped into a microfuge tube,
lipids extracted by soaking in 1:1 CHCl3:MeOH and quantitated using a cuvette or plate
reading fluorimeter.
Results confirming phosphatase activity of LPPs in assays incorporating dual labeled
([3H] and [32P]) LPA as a substrate, would demonstrate equivalent rates of Pi release and
MAG production. If any phosphotransferase activity has occurred, the rate of MAG
production will exceed that of Pi formation. Furthermore, autoradiography of a TLC plate
should reveal new [32P]-labeled lipid species that have resulted due to the transfer of the
78
phosphate group from LPA onto a different lipid moiety. It should be noted that LPPs do not
exhibit any phosphotransferase activity when tested under these conditions (McDermott et
al., 2004), but this assay can be used effectively to study the activities of other LPTs such as
SMSases, and was used previously to confirm enzymatic inactivity of LPRs (McDermott et
al., 2004).
5.9 Determination of LPP activity in intact cells using substrates complexed with BSA
5.9.1 Substrate Preparation: Radiolabeled or fluorescently labeled substrates are
combined in a polypropylene tube and evaporated to dryness. Substrates are resuspended in
culture medium containing 0.1% fatty acid free BSA by bath sonication to give a final
substrate concentration of 1-10 µM.
5.9.2 Incubation and product analysis. Cells are cultured in 35 mm diameter dishes
or 6-well tissue culture plates. Cells are washed in serum-free cell culture medium and
assays initiated by addition of 1 ml of substrate-containing medium to the cells. Incubations
are conducted in a tissue culture incubator and terminated by removal of the culture medium.
The cells are extracted by addition of 0.4 ml ice cold MeOH with scraping and removal to a
polypropylene tube, and any material remaining removed with an additional wash with 0.2
ml ice cold MeOH which is combined with the first extraction before addition of 0.7 ml
CHCl3 and 0.4 ml 2M NaCl. After vortexing and centrifugation, the upper aqueous phase is
recovered for analysis of water soluble reaction products and the lower organic phase kept
for lipid analysis by thin layer chromatography as described (5.8.2). The culture medium is
processed for analysis of lipids and water soluble reaction products by extraction with 3.75
ml 200:400:5 CHCl3:MeOH:concHCl followed by 1.25 ml of CHCl3 and 1.25 ml of 0.1 M
HCl as described (5.8.2).
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5.10 Determination of LPP-promoted lipid uptake by intact cells
5.10.1 Preparation of lipid vesicles- 16:0-18:1 (palmitoyl-oleoyl PC), NBD or
BODIPY PA or LPA in CHCl3 solution are combined at a molar ratio 20:5 in a
polypropylene tube and evaporated to dryness under vacuum and resuspended in culture
medium by bath sonication to give a total concentration of resuspended lipid of 100 µM. Rh-
PE may be included in these vesicles as 3.8% of total lipid, making the vesicles 20:5:1
PC/BODIPY-PA/Rh-PE.
For studies using mammalian cells, lipids are resuspended in DMEM without
bicarbonate and phenol red but containing 20 mM HEPES, pH 7.5 (HEPES buffered
DMEM). For insect cells analyses, the lipids are resuspended in Grace’s media.
5.10.2 Incubation and lipid extraction- Mammalian cells are cultured in 35 mm
diameter dishes (~2-5 x 104 cells/dish). The culture medium is removed and the cells are
washed once in HEPES buffered DMEM and then incubated with medium containing lipid
vesicles at final concentrations of 20-100 µM total lipid for times ranging from 5-60 minutes.
Incubations are terminated by removal of the culture medium and washing the cells twice
with phosphate buffered saline. Lipids are extracted from the cells and analyzed by TLC
exactly as described (5.9.2).
Similarly, Hi5 insect cells that are cultured in suspension are resuspended in Grace’s
media at a concentration of 2-5x105 cells/assay. The cells are washed once in serum free
media, and are incubated with lipid vesicles at a final concentration of 20-100 µM total lipid
for 15-30 minutes. Incubations are terminated, and lipids are analyzed by the same methods
as used for analyses of lipid uptake in mammalian cells.
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5.10.3 Visualization of cells by fluorescence microscopy- Mammalian cells are
cultured on cover glasses that can be coated with poly-L lysine, collagen or fibronectin to
enhance cell adhesion. Lipid accumulation in live cells can be examined immediately by
fluorescence microscopy. Alternatively, the cells can be fixed with 4% paraformaldehyde
and mounted in antifade reagent to abrogate photobleaching. Insect cells are non-adherent
and are maintained in suspension culture. Prior to imaging they are fixed in 4%
paraformaldehyde and mounted onto a coverslip using antifade reagent.
5.10.4. Notes and tips for troubleshooting: In comparison to untransfected cells or
cells expressing enzymatically inactive LPP mutants, overexpression of LPPs in mammalian
or insect cells results in 2-4-fold increases in the rate of accumulation of cell-associated lipid
fluorescence in these assays (Figure 2.6).
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Figure 2.6 Lipid Uptake of Insect Cells Expressing Wunen and Wunen Mutants
(Renault et al., 2004). Fluorescence (A. C. E. G. I. K.) and phase contrast images (B. D. F.
H. J. L.) of Hi5 cells expressing a control protein (A. B.), hLPP1 (C. D.), wild-type Wun2
(E. F.) or mutant forms of Wun2 including H274K (G. H.) or H326K (I. J.), which are both
catalytically dead or Y225W (K. L.), which is catalytically active, after 15 minute exposure
to NBD-PA. M. Relative fluorescence of Hi5 cells after exposure to the fluorescent PA
analog NBD-PA, expressing a control protein, hLPP1, wild-type or mutant forms of Wun2.
N. Western blot confirming expression of tagged wild-type and mutant Wun2 proteins.
Figure Reprinted from: Science 305, 1963-6.
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6. CONCLUDING COMMENTS
Although they catalyze relatively simple dephosphorylation reactions, LPPs are
emerging as complex regulators of diverse cellular and physiological processes. In large part,
the biological activities of LPPs are due to their ability to dephosphorylate lipid substrates,
altering the balance of bioactive lipids both inside cells and in the extracellular space. LPPs
belong to a larger family of genes we have termed lipid phosphatases/phosphotransferases
(LPTs) that includes the sphingosine phosphate phosphatases and sphingomyelin synthases.
The recent realization that this family also includes groups of proteins with variant catalytic
motifs that may be enzymatically inactive or have distinct catalytic properties emphasizes the
need for continued development of methods for enzymatic analysis members of the LPT
family (Sigal et al., 2005). The assays described here have proved effective for detection,
quantitation and analysis of LPP activities in cells and tissues and the use of fluorescent lipid
substrates provides a way to investigate LPP activity at the surface of intact cells. However,
it is important to note that each of these assays employs substrate preparations that are
necessarily artificial. The development of assays to monitor and localize endogenous LPP
activity in live cells, for example assays that employ substrates with fluorescence properties
that are altered as a consequence of LPP-catalyzed hydrolysis, remains a major challenge in
the field.
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CHAPTER 3
CDC42 AND ARP2/3-INDEPENDENT REGULATION
OF FILOPODIA BY AN INTEGRAL MEMBRANE
LIPID PHOSPHATASE RELATED PROTEIN
Reproduced with permission of the Company of Biologists from: J Cell Sci 120, 340-52.
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1. ABSTRACT
Filopodia are dynamic cell surface protrusions that are required for proper cellular
development and function. We report that a member of a Phosphatase/Phosphotransferases
(LPT) family of integral membrane proteins, Lipid Phosphatase Related Protein 1 (LPR1),
localizes to and promotes the formation of actin-rich, dynamic filopodia both along the cell
periphery and the dorsal cell surface. Regulation of filopodia by LPR1 is not mediated by
cdc42 or Rif, and is independent of the Arp2/3 complex. We found that LPR1 can induce
filopodia formation in the absence of Ena/Vasp family of proteins, suggesting that these
molecules are not essential for the development of these protrusions. Mutagenesis
experiments identify residues and regions of LPR1 that are important for the induction of
filopodia. RNA interference experiments in an ovarian epithelial cancer cell line
demonstrate a role for LPR1 in the maintenance of filopodia-like membrane protrusions.
These observations, and our finding that LPR1 is a not an active lipid phosphatase, suggest
that LPR1 may be a novel integral membrane protein link between the actin core and the
surrounding lipid layer of a nascent filopodium.
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2. INTRODUCTION
Actin rich membrane protrusions are important for many cellular functions, including
signaling, neurite outgrowth (Kalil and Dent, 2005), migration and attachment (Perez-
Moreno et al., 2003). Regulation of actin organization in cells has been primarily attributed
to the functions of small Rho family GTPases (Bishop and Hall, 2000; Nobes and Hall,
1995). Cdc42 has been implicated in regulation of tightly bundled actin filaments that extend
from the cell periphery (Etienne-Manneville and Hall, 2002; Nobes and Hall, 1995). These
protrusions arise deep within the dendritic actin network, where the growing barbed ends of
actin filaments extend and push against the plasma membrane (Wood and Martin, 2002).
The filaments are joined together by bundling proteins resulting in straight protrusions, called
filopodia (Svitkina et al., 2003). Filopodia vary considerably in length and width, and have
distinct patterns of cell surface localization that likely contribute to their diverse
physiological roles (Passey et al., 2004). In the absence of concrete molecular
characterization, filopodia are broadly classified as slender membrane protrusions that
contain a core of a bundled actin filaments (Wood and Martin, 2002). However, in light of
recent advances in identification of mechanisms underlying filopodia formation,
classification of these structures can now be based more on the presence of protein
machinery responsible for their biogenesis rather then on structural appearance alone.
The best characterized mechanism for the formation of filopodia is termed the
“convergent elongation” model which postulates that initiation of filopodia requires
activation of the Wiskott-Aldrich syndrome protein (WASP) by cdc42, which in turn recruits
and activates the Arp2/3 complex (Svitkina et al., 2003; Welch and Mullins, 2002). Arp2/3
acts as an actin nucleating complex by binding to the side of an existing actin filament and
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promoting the growth of a new filament at a 70º angle, thereby generating a branched actin
network (Svitkina and Borisy, 1999; Welch and Mullins, 2002). Actin cross-linking proteins
such as fascin, can bundle several of these filaments together, which then elongate to form a
filopodium (Faix and Rottner, 2006; Svitkina et al., 2003). Capping proteins bind to the tips
of actin filaments, thus blocking polymerization and elongation at the barbed ends.
Filopodia, however, have Ena/Vasp proteins at their tips (Bear et al., 2000; Bear et al., 2002)
which are thought to displace capping proteins and act as “leaky caps”, facilitating the
addition of actin monomers to elongate the growing filopodia.
Recent evidence, however, has revealed that the convergent elongation model is not
universally applicable. Genetic inactivation of cdc42 demonstrated that it is not required for
the formation of filopodia in embryonic stem cells (Czuchra et al., 2005). Formation of
filopodia was observed in WASP deficient cells (Snapper et al., 2001), while depletion of the
Arp2/3 complex did not abolish filopodia formation in B16F1 cells (Steffen et al., 2006).
More significantly, recent studies have shown that Vasp may not exhibit any anti-capping
activity (Samarin et al., 2003), but may rather act as actin bundling protein required for the
formation of filopodia (Schirenbeck et al., 2006). These discrepancies clearly imply that
alternate mechanisms for formation of filopodia exist that do not require the Arp2/3 complex,
may not depend on cdc42, and likely employ anti-capping proteins other then Vasp.
Diaphanous related formins, such as p134mDia2/Drf3 (mDia2) nucleate actin
polymerization independently of Arp2/3 (Evangelista et al., 2003). This large protein exists
in a basal auto inhibited conformation, where the N-terminal Rho Binding Domain (RBD) is
associated with the C-terminal Diaphanous Autoinhibitory Domain (DAD), masking the FH2
domain responsible for actin nucleation. When the RBD associates with a small GTPase, the
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FH2 domain becomes accessible to promote actin polymerization (Evangelista et al., 2003;
Peng et al., 2003). Cdc42 has been shown to activate and regulate the activity of mDia2
through interaction with the CRIB (Cdc42/Rac inreactive binding) motif of the formin’s Rho
Binding Domain (RBD) (Peng et al., 2003). mDia2 is also necessary for a novel GTPase
called Rho in filopodia (Rif) to induce filopodia in mammalian cell lines independently of
cdc42 (Pellegrin and Mellor, 2005). In Dictyostelium discoideum the formin dDia2 has also
been shown to be necessary for initiation and maintenance of filopodia (Schirenbeck et al.,
2005). Although dDia2 is not a complete functional ortholog of mDia2, the two formins
share similar characteristics; they are localized to the tips of filopodia where they may serve
the dual function of leaky-cappers and actin nucleators to promote filopodial growth (Higgs,
2005; Nicholson-Dykstra et al., 2005).
Induction of filopodia clearly requires more than simply nucleation of actin
polymerization. Actin bundling proteins such as fascin are required to link parallel actin
filaments (Svitkina et al., 2003), and unconventional myosins play a role in transport of
proteins along the filopodial core (Sousa and Cheney, 2005). Interactions between these
myosins and integrin -subunits, as well as focal adhesion proteins, may localize these
molecules to the shaft and tips of filopodia leading to adhesion of the filopodium to the
substratum (Zhang et al., 2004). Formation of filopodia clearly also requires dramatic
reorganization of planar regions of the plasma membrane to form a tightly curved membrane
“cylinder” that sheaths the actin core. However, almost nothing is known about the lipid
composition of filopodia or, aside from the presence of integrins, about other types of
filopodia-localized integral membrane proteins that may play roles in membrane
reorganization, or in the localization or tethering of the actin-based machinery responsible for
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filopodial growth to the inner surface of the plasma membrane. In this paper, we describe a
novel integral membrane protein, called Lipid Phosphatase Related Protein 1 (LPR1) that,
when overexpressed, in HeLa and Cos7 cells, induces the formation of long and thin
filopodia from both the periphery and dorsal surface of the cell. We identify structural
determinants in LPR1 that are required for the formation of filopodia. Formation of filopodia
by LPR1 is not regulated by cdc42 or Rif and does not require Ena/Vasp family proteins.
3. RESULTS
Previous work from our laboratory and others identifies a family of integral
membrane proteins that we collectively termed Lipid Phosphatases/Phosphotransferases
(LPTs) (Sigal et al., 2005). This family consists of five groups of proteins, most of which are
enzymes that either dephosphorylate lipid phosphates, or catalyze transphosphatidylation
reactions involved in the metabolic interconversion of phosphatidylcholine and
sphingomyelin. One of the less well-studied groups of the LPT family contains four genes,
which we provisionally termed Lipid Phosphatase Related (LPR) proteins (Chapter 1). Like
all LPT family members, these proteins contain a core domain with six predicted
transmembrane helices linked by intra and extra membrane loops. The third of these
contains a consensus glycosylation sequence. The active site of the LPT family enzymes is
formed from residues within the third and fifth extramembrane loops (Figure 3.1A).
However, comparison of the relevant regions of the LPR proteins with those of other
members of the LPT family reveals that a number of critical catalytic residues are missing.
((Sigal et al., 2005). This observation implies that LPR proteins could not catalyze lipid
phosphatase or phosphotransferase reactions using the mechanism defined for
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Figure 3.1 LPR1 is a Broadly Expressed Integral Membrane Protein with a Variant Lipid Phosphate
Phosphatase Catalytic Motif.
A. I. The deduced amino acid sequence of human LPR1 is shown with hydrophobic residues that are predicted
to form six transmembrane -helices highlighted in yellow. Residues corresponding to the consensus
phosphatase motif found on the LPPs and other family members are highlighted in red. The site of
glycosylation is highlighted in purple and the sequence used to generate the LPR1 antibody is boxed. Residues
shown in green font were mutated as described in the text. The C-terminus highlighted in green corresponds to
the last 43 residues deleted to form the LPR1 C-term 43 mutant described in the text. II. The consensus
phosphatase sequence motif is shown in alignment with cognate sequences from four proteins of the LPR
family. Residues that participate in the charge relay catalytic mechanism of the phosphatase reaction are
highlighted in red and residues that contact the substrate or transition state phosphate group are highlighted in
blue. Residues within this motif that are divergent in LPR1 and related proteins are underlined. B. Membrane
protein preparations from insect cells expressing LPP1 or LPR1 were analyzed by western blotting using an
LPR1-specific antibody. Asterisk denotes an LPR1-specific immuno-reactive band of expected size, 35-38kDa.
Samples contained equal quantities of proteins. C. LPR1 expression in mouse tissues was analyzed by western
blotting. Samples contained equal quantities of protein.
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other LPT family enzymes. To explore this issue directly, LPR1 was expressed in insect
cells using a baculovirus vector. This system is highly effective for expression and
characterization of another group of LPT proteins, the Lipid Phosphatase Phosphatases
(LPP). Because endogenous levels of LPP activity are low in these cells, strong
overexpression obtained using baculovirus vectors allows the use of membranes or detergent
membrane extracts from LPP expressing cells as a source of protein for measurements of
enzyme activity (Roberts et al., 1998). Recombinant LPR1 was detected as a strongly
immunoreactive species of the expected molecular weight using an antibody raised against an
LPR1-specific peptide sequence that is conserved between the murine and human forms of
the protein (Figure 3.1B). The higher molecular weight species likely represents an
aggregated form of this hydrophobic protein. LPPs1-3 exhibit characteristically broad
specificity for a range of lipid phosphate substrates and are highly active against substrates
presented in mixed micelles with non-ionic detergents (Brindley and Waggoner, 1998).
Hydrolysis of four well characterized LPP substrates, lysophosphatidic acid (LPA),
phosphatidic acid (PA), sphingosine 1-phosphate (S1P) and ceramide 1-phosphate (C1P) was
measured by detergent extracts from Sf9 cells infected with a control virus or with viruses for
expression of LPP1 or LPR1. Whereas dramatic (~250-fold) increases in activity against
each of these substrates were observed in extracts from cells expressing LPP1, there was no
significant increase in phosphatase activity against any of these substrates in extracts from
LPR1 expressing cells (Table 3.1). LPPs1-3 can also hydrolyze substrates in complex with
BSA, but again no increases in hydrolysis were observed when these substrates were
incubated with extracts from cells expressing LPR1. These observations are consistent with
our previous findings that intact mammalian cells expressing either LPR1 or LPR3, or
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membrane fractions derived from these cells, do not exhibit increased LPA phosphatase
activity (McDermott et al., 2004).
RNA analysis suggests that LPR1 is a widely expressed protein (Sigal et al., 2005).
To explore this directly, expression of LPR1 in different mouse tissues was examined by
western blotting. LPR1 was detected as a doublet of immunoreactive protein with molecular
weights of approximately 35-38 kDa were detected in all tissues examined (Figure 3.1C). As
noted above, LPR1 contains a consensus glycosylation site within the third extramembrane
loop. Studies using epitope tagged recombinant LPR1 identify N165 as the site of
glycosylation, and we observed that the LPR1 species of lower mobility on SDS PAGE could
be converted to the more mobile species by treatment with N-glycosidase (unpublished
observations). These results indicate that the immunoreactive LPR1 species detected in
mouse tissues likely represent immature and mature glycosylated forms of the protein.
EGFP-LPR1 labels dynamic, actin rich membrane protrusions we identify as
filopodia- LPR1, also termed PRG3, has been previously reported to induce formation of
‘neurites’ when expressed in cultured N1E-115 and Cos7 cells, although no characterization
of these structures was performed (Savaskan et al., 2004). LPR1 was expressed in HeLa and
Cos7 cells by transient transfection. The recombinant protein incorporated a C-terminal
EGFP tag. Western blot analyses of extracts from these cells revealed that the EGPF-LPR1
protein was strongly expressed at the predicted molecular weight (data not shown, Figure
3.2E and McDermott et al, 2004). Indirect immunofluorescence analysis of fixed cells
revealed that the protein was localized to both intracellular membrane structures (most likely
the endoplasmic reticulum and Golgi apparatus) and to the plasma membrane. Distribution
of LPR1 along the plasma membrane appeared discontinuous, with a pronounced localization
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Figure 3.2 LPR1 Localizes to and Increases the Number of Actin-rich Membrane Protrusions in HeLa
and Cos7 Cells.
Cos7 cells were transfected with pEGFP, pEGFP-LPP3 (A) and pEGFP-LPR1 (B) and the distribution of
EGFP-tagged protein and actin organization were visualized by immunofluorescence microscopy. C. A bar
graph comparing the number of filopodia, dorsal and peripheral, as visualized by phalloidin staining, in
untransfected (control) Cos7 cells and Cos7 cells expressing either EGFP or EGFP-LPR1. Twenty cells were
counted for each category; error bars denote s.d. for each group. D. HeLa cells were transfected with pEGFP-
LPR1 and localization of the protein and actin organization were determined by fluorescence microscopy. All
images were acquired and processed identically. Panels B and D contain higher magnification images of
sections of the cell periphery that are derived from the larger images to show actin staining and LPR1
localization to filamentous structures. E. Cell lysates from HeLa cells transfected with pEGFP, pEGFP-LPP3
or pEGFP-LPR1 were examined by western blotting with a GFP specific antibody. Each lane was loaded with
equal amounts of total proteins. F. Cos7 cells were transfected with pEGFP-LPR1, fixed, counter stained with
rhodamine phalloidin, and analyzed by confocal microscopy. Images are shown as projections of z sections in
both rhodamine and GFP channels. G. Cos7 cells were transfected with pEGFP-LPR1, and examined live by
confocal microscopy. The image represents a projection of z sections at a single time interval in a GFP-specific
channel. Bars, 10µm.
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to many thin membrane protrusions up to ~5 µm in length. LPR1 was predominantly
distributed uniformly along the shafts of these protrusions with an occasional enrichment at
their tips (Figure 3.2B, D). We do not know the extent to which this apparent enrichment of
LPR1 to these protrusions results from their increased membrane density in comparison to
other regions of the plasma membrane. Analysis of cells expressing LPR1 by wide-field and
confocal fluorescence microscopy showed that these protrusions were rich in polymerized
actin and were distributed around both the periphery and across the dorsal surface of the cell
(Figure 3.2B,D,F). These types of membrane protrusions were not labeled when EGFP-
tagged LPP3 (an enzymatically active LPP that also localizes to the plasma membrane and
intracellular membranes) or EGFP alone were expressed in these cells (Figure 3.2A).
Because GFP can self-associate (Yang et al., 1996), we were concerned that the dramatic
morphological phenotype induced by expression of EGFP-LPR1 might be artifactually
produced by clustering of the GFP tags, resulting in an accumulation of the overexpressed
integral membrane protein which could in turn distort the plasma membrane. To address this
issue, LPR1 containing a C-terminal HA epitope tag was expressed in Cos7 and HeLa cells
which were examined by indirect immunofluorescent microscopy (Figures 3.3 and 4.3).
Overexpression of HA-LPR1 resulted in the labeling of multiple actin-rich filopodia that
were identical to filopodia observed upon transient expression of EGFP-LPR1.
Because of concerns about preserving fragile membrane protrusions in fixed
specimens, we also examined EGFP-LPR1 expressing live Cos7 cells by confocal
microscopy. Again, we observed labeling of many membrane protrusions, both at the cell
periphery and across the dorsal surface (Figures 3.2G). We used video microscopy to
analyze the dynamics of the structures labeled with LPR1 in live cells. Dynamic protrusions,
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such as filopodia, should exhibit both retractile and protrusive behavior, independent from
the movement of the cell (Atilgan et al., 2006). These could be distinguished by time lapse
microscopy from retraction fibers, which are formed by membrane remnants that remain
anchored as motile cells move across the substratum. Figures 3.4A and 3.4B show a time-
resolved series of phase and EGFP fluorescence images of a section of two different HeLa
cells expressing EGFP-LPR1. Panels in Figure 3.4A showed that in a time period of six
minutes the majority of LPR1-labeled protrusions were retracting relative to the motionless
cell. Images in Figure 3.4B illustrated that LPR1-labeled projections were extending
throughout a period of three minutes, with a few nascent LPR1-labeled protrusions forming
from the periphery of the stationary cell. The videos, from which the data shown in figure
3.4A is derived, are presented as supplementary video 3.4A, while images from figure 3.4B
are acquired from supplementary video 3.4B. Taken together, the highly dynamic nature of
the filamentous plasma membrane protrusions observed in cells expressing LPR1, their
morphology and actin composition, identifies them as filopodia.
Figure 3.3 HA- LPR1 Expressing HeLa Cells Extend Multiple Actin-rich Protrusions.
HeLa cells were transfected with a plasmid for expression of LPR1 with a C-terminal HA
tag. Ha tagged proteins and actin were visualized by fluorescence microscopy. Bar, 10µm.
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Figure 3.4 LPR1 Labeled Filopodia are Dynamic and Exhibit Both Retractile and Protrusive
Motion.
Phase contrast (lower frame) or EGFP fluorescence (upper frames) images of two HeLa cells
expressing EGFP-tagged LPR1 are shown. The panels are individual frames taken from Videos 3.4A
and 3.4B of the supplemental material. The numbers on each panel denote the time at which each
image was captured. A. Arrows denote filopodia that steadily diminished in length throughout the
period observed. B. Arrows in each panel indicate either newly formed filopodia or filopodia that
have increased in length when compared to the previous time frame. Bars, 10µm.
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Overexpression of LPR1 increases the number of filopodia in different cell
types- To ascertain whether overexpressed LPR1 localizes to and labels preexisting
filopodia, or itself induces the formation and labeling of new filopodia, we quantitated actin
rich phalloidin stained plasma membrane protrusions in both HeLa and Cos7 cells expressing
EGFP-LPR1 and compared this to cells expressing EGFP alone. HeLa cells have a strongly
defined actin cytoskeleton, which when labeled with phalloidin to visualize actin, masks
actin-rich dorsal protrusions because of the presence of numerous cytoplasmic actin stress
fibers. For this reason, quantitation of filopodia in HeLa cells was limited to counting
peripheral filopodia. Despite this limitation, an approximate doubling in the number of these
protrusions was observed in these cells (Data not shown). Cos7 cells are more uniform in
size then HeLa cells, and have fewer stress fibers, making it easier to visualize and count
dorsal filopodia, allowing for a more precise estimate of the effects of LPR1 expression on
the number of filopodia displayed by these cells. We therefore quantitated both dorsal and
peripheral filopodia in Cos7 cells expressing EGFP-LPR1 and compared this number to the
number of filopodia in cells expressing EGFP alone. The results (Figure 3.2C) illustrate that
there is an approximately six-fold increase in the number of filopodia in Cos7 cells
expressing EGFP-LPR1 (64.4 filopodia cell-1) versus untransfected (control) or EGFP
expressing cells, which exhibit a mean number of 10.5 filopodia cell-1 each. Overexpression
of LPR1, therefore, results in an approximate doubling in the number of peripheral filopodia
in HeLa cells and an approximately 6-fold increase in the total number of filopodia in COS7
cells, the majority of which are on the dorsal surface. In both cell types, all filopodia
detected by actin staining also contained LPR1 suggesting that, in addition to inducing and
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labeling new filopodia, LPR1 also localizes to filopodia that are formed spontaneously by
these cells.
Figure 3.5 Analyses of Residues and Regions of LPR1 that are Important for the Induction of Filopodia.
HeLa cells were transfected with plasmids for expression of LPR1 mutants: EGFP-LPR1 S198T, EGFP-LPR1
H200G, EGFP-LPR1 R246E (A), as well as the C-terminal mutant, EGFP-LPR1 C-term 43 (B). Cells were
analyzed by fluorescence microscopy to determine the localization of EGFP tagged proteins and actin. C.
Untransfected (control) HeLa cells, or HeLa cells transfected with either EGFP-LPR1 or EGFP-LPR1 C-term
43 were examined by fluorescent microscopy, and peripheral filopodia were quantitated as described in the
text. Twenty five cells were counted in each category and mean numbers of filopodia ± s.d. were plotted. D.
HeLa cells were transfected with vectors for expression of EGFP, EGFP-LPP3, EGFP-LPR1, and three mutants
of EGFP-LPR1, described in the text. Cell lysates were generated and analyzed by western blotting for
expression of EGFP tagged proteins with a GFP specific antibody. Bars, 10µm.
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Identification of residues and regions of LPR1 that are important for the
induction of filopodia- LPR1 contains a variant LPT catalytic motif in which amino acid
residues critical for catalysis are not conserved. Attempts to “restore” catalytic activity of
LPR1 by reconstituting the active site using site-directed mutagenesis were not successful
(data not shown). However, in the course of these studies, we identified a possible role for
residues within the “catalytic core” of the protein in the induction of filopodia. LPR1
variants containing non conservative substitutions of residues serine 198 and histidine 200
within the C2 motif and arginine 246 from the C3 motif (Figure 3.1A) were found to be
strongly expressed in transient transfection experiments but failed to induce the formation of
filopodia in HeLa cells (Figure 3.5A, D). In contrast to wild type LPR1, these mutant LPR1
proteins were, within the detection limits of our experiments, exclusively localized to
intracellular membranes. These residues are predicted to be involved in substrate recognition
by active members of the LPT family, and substitution of these residues in members of the
LPP family produces inactive enzymes (Sigal et al., 2005; Starz-Gaiano et al., 2001).
Although LPR1 is enzymatically inactive, association of LPR1 with as yet unidentified lipids
may therefore be important for trafficking of the protein to the plasma membrane and in the
induction of filopodia.
Alignment of all four LPR family members revealed that a short sequence within the
C-terminus proximal to the final transmembrane domain is highly conserved within this
family of proteins. A variant of LPR1 in which the C-terminal 43 residues was deleted
(EGFP-LPR1 C-term 43) exhibited a significantly attenuated ability to induce the formation
of peripheral filopodia in HeLa cells in comparison to wild type LPR1 despite being
expressed at a comparable level (Figure 3.5B, C). In contrast to the point mutants described
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above, subcellular distribution of EGFP-LPR1 C-term 43 between the plasma membrane
and intracellular membranes was highly comparable to that of wild type LPR1. Since the
number of peripheral filopodia observed in cells expressing EGFP-LPR1 C-term 43 was
equivalent to the number of peripheral filopodia observed in control cells, as determined by
phalloidin staining (Figure 3.5C), we suggest that LPR1 C-term 43 mutant is incapable of
generating new filopodia, but rather localizes to pre-existing endogenous protrusions
extended by these cells. These results identify a critical role for the C-terminal 43 amino
acids of LPR1 in the induction of filopodia.
Induction of filopodia by overexpression of LPR1 is independent of the small
GTPase cdc42 and its effectors- Overexpression of activated alleles of several small
GTPases, most prominently cdc42, induces the formation of membrane protrusions in many
cell types (Etienne-Manneville and Hall, 2002). HeLa cells expressing constitutively active
cdc42 Q61L extended membrane protrusions that were noticeably thicker and shorter than
membrane extensions labeled by expression of EGFP-LPR1 (Figure 3.6A, compare to Figure
3.2D). Furthermore, HeLa cells expressing constitutively active cdc42 were noticeably
smaller and rounder then both wild type cells, and cells expressing EGFP-LPR1. Induction
and labeling of filopodia in EGFP-LPR1 expressing cells was apparent 12-24 hours after
transfection and maintained for up to 48 hours, while extension of filopodia observed in cells
expressing cdc42 Q61L was markedly more transient. Expression of the dominant negative-
acting cdc42 mutant, cdc42 T17N, had no obvious effects on cell morphology (Figure 3.6A).
Formation of filopodia by EGFP-LPR1 was not attenuated by co-expression with Cdc42
T17N in HeLa cells (Figures 3.6B, 3.7C) or Cos7 cells (data not shown), suggesting that the
effect of LPR1 on formation of filopodia is not mediated by cdc42.
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Figure 3.6 Effects of LPR1 on Filopodia are not Mediated by the Small GTPase Cdc42.
A. HeLa cells were transfected with vectors for expression of myc tagged cdc42 Q61L or
cdc42T 17N. HeLa cells were transfected with vectors for expression of EGFP-LPR1 and
myc tagged constructs of cdc42 T17N (B), Wasp-CRIB (C) and Scar-WA (D). In all cases,
EGFP- and myc-tagged proteins and actin organization were visualized by fluorescence
microscopy. Bars, 10µm.
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To further explore the possible involvement of cdc42 and its effector, the Arp2/3
complex, in the formation of filopodia in LPR1 expressing cells, we employed strategies
recently used in the study of another small GTPase, Rif, as a novel regulator of filopodia
(Pellegrin and Mellor, 2005). EGFP-LPR1 was co-expressed with a WASP CRIB motif,
which has been shown to sequester and thereby inhibit the function of cdc42 (Nobes and
Hall, 1999; Pellegrin and Mellor, 2005). Co- expression with this construct had no effect on
the ability of LPR1 to induce filopodia in HeLa cells (Figure 3.6C). EGFP-LPR1 was also
co-expressed with the SCAR WA domain that has been reported to sequester and thereby
inhibit the function of Arp2/3 (Machesky and Insall, 1998; Pellegrin and Mellor, 2005).
Again there was no decrease in the number of filopodia in cells expressing the two
constructs (Figure 3.6D); however, the overall morphology of the cells was slightly affected
by expression of this protein fragment.
LPR1-induced filopodia resemble filopodia produced by expression of Rif, but
are not attenuated in the presence of dominant negative Rif construct- HeLa cells
expressing either wildtype (Rif WT) or constitutively active Rif (Rif Q75L) extend numerous
filopodia from both the dorsal and peripheral surfaces ((Pellegrin and Mellor, 2005). These
protrusions closely resemble filopodia induced and labeled by LPR1 in length and thickness
and cellular orientation. Co-expression of a dominant-negative acting mutant of Rif, Rif
T33N, with EGFP-LPR1 in HeLa cells did not abolish or diminish filopodia extended by
these cells (Figure 3.7B, C). These results suggest that LPR1 does not function upstream of
Rif in regulation of filopodial organization but do not exclude the possibility that LPR1 and
Rif operate through a common effector pathway.
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Figure 3.7 LPR1-induced Filopodia Resemble Filopodia Produced by Expression of Rif, but LPR1-
induced Filopodia are not Attenuated by Co-expression with a Dominant Negative-acting Rif
Mutant.
A. HeLa cells were co-transfected with plasmids expressing EGFP and either myc tagged wildtype Rif
(Rif WT myc), or myc tagged constitutively active Rif (Rif Q75L myc). B. HeLa cells were co –
transfected with vectors encoding for myc tagged dominant negative Rif (Rif T33N myc) and either EGFP
alone or EGFP tagged LPR1 (EGFP-LPR1). In both panels A and B EGFP-and myc-tagged proteins, as
well as actin, were examined by fluorescent microscopy. C. HeLa cells were transfected with EGFP-
LPR1 and either pcDNA, Rif T33N myc or myc-Cdc42 T17N. EGFP-LPR1 labeled dorsal and peripheral
filopodia were counted in 25 individual cells. The data show are means ± s.d. Bars, 10µm.
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LPR1-labeled filopodia have a unique protein composition- In some cell types,
the tips of cdc42-regulated filopodia contain focal adhesion proteins, such as paxillin and
vinculin (Nobes and Hall, 1995). HeLa cells transiently expressing EGFP-LPR1 lack
paxillin at the tips of LPR1 labeled filopodia (Figure 3.8A). These focal adhesion markers
were predominantly localized to the base of LPR1 based filopodia, most prominently
between adjacent protrusions. Vasp, another component of focal adhesions (Bear et al.,
2000; Holt et al., 1998), is also a putative anti-capping protein that is localized to the tip
complex of cdc42 - induced filopodia (Krugmann et al., 2001; Welch and Mullins, 2002). In
contrast, we observed that although Vasp was clearly detected at the tips of cdc42 mediated
filopodia (Figure 3.9), within the detection limits of our experiments, it was excluded from
the tips and shafts of LPR1 –labeled filopodia (Figure 3.8B). As observed with another focal
adhesion protein, paxillin, VASP was localized to the base of LPR1 labeled filopodia, where
it may function in maintaining cellular attachment to the substratum. Two VASP homologs,
Mena and Evl, exhibited identical localization patterns (Data not shown).
We examined the localization of several additional proteins to filopodia induced by
overexpression of activated LPR1. Myosin X, localizes to the tips of cdc42 mediated
filopodia, where it may function in the transport of proteins to the filopodial tips (Sousa and
Cheney, 2005; Tokuo and Ikebe, 2004). Our results (Figure 3.8C) indicated that myosin-X
also clearly localizes to the tips of filopodia in HeLa cells expressing LPR1. Actin bundling
proteins, such as fascin are crucial proteins for the formation of filopodia and filopodia like
structures in vivo and in vitro (Svitkina and Borisy, 1999; Vignjevic et al., 2003). In fact
fascin is considered to be a definitive marker for filopodia. Indirect immunofluorescence
analysis using the fascin-specific antibody used in this study requires treatment of cells with
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Figure 3.8 LPR1-labeled Filopodia have a Unique Protein Composition.
HeLa cells were transfected with pEGFP-LPR1, and immunofluorescence microscopy was
used to visualize EGFP tagged LPR1 and different endogenously expressed proteins: Paxillin
(A), Vasp (B) and Myosin X (C). Cos7 cells were transfected with vectors for expression of
EGFP-LPR1 and localization of endogenous fascin (D) and EGFP-LPR1 were analyzed by
immunofluorescence microscopy. Fascin labels intracellular structures as well as membrane
protrusions, therefore panel D exhibits higher magnification images of the periphery of the
cells to show how these markers localize exclusively within the filopodia. Bars, 10µm.
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methanol, followed by paraformaldehyde fixation, which sometimes results in a loss of fine
structures such as filopodia. Fascin uniformly decorated the shafts of LPR1 labeled filopodia
in Cos7 cells, suggesting that formation of filopodia by LPR1 is likely to require the actin
bundling activity of this protein. Similar results were seen in HeLa cells, although filopodia
in this cell line was not well preserved following treatment with methanol (Data not shown).
Figure 3.9 Vasp is Localized at the Tips of Cdc42-filopodia.
HeLa cells were transfected with a vector for expression of myc-tagged constitutively active cdc42
(cdc42 Q61L). Myc tagged protein and endogenously expressed Vasp were visualized by
fluorescence microscopy. Bar,10µm.
LPR1 induces filopodia in the absence of Ena/Vasp proteins- Given that, within
the detection limits of the immunofluorescence approach, we were not able to detect any
endogenous Vasp at the tips of LPR1-induced filopodia, a concern was raised that the slender
nature of these protrusions limited our ability to detect any visible amounts of these proteins
at the tips of these structures. To fully dissect the role of Vasp in LPR1 mediated filopodial
protrusion we expressed EGFP-LPR1 in MVD7 cells. These cells have been engineered to
lack any of the three members of the Vasp family (Bear et al., 2000). Scanning electron
microscopy of these cells has showed that they lack any endogenous dorsal filopodia, and
have very few endogenous peripheral protrusions (Bohil et al., 2006). MVD7 cells expressing
EGFP-LPR1 extend numerous filopodia from the periphery and especially the dorsal surface
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of the cell. These are clearly labeled with actin (Figure 3.10A) and fascin (Figure 3.10B)
suggesting that these structures are true filopodia. This result definitively demonstrates that
LPR1 can generate filopodia in the absence of Vasp, or its functional homologues.
Figure 3.10 LPR1 Forms Filopodia in the Absence of Ena/Vasp Proteins.
MVD7 cells were transfected with vectors for expression of either EGFP or EGFP-LPR1 and
visualized by fluorescent microscopy to analyze GFP fluorescence and either actin (A), or fascin (B).
Bars, 10µm.
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LPR1 is required for maintenance of membrane protrusions in Ovarian
Epithelial Cancer Cells- Because overexpression of LPR1 increased the number of
filopodia in HeLa, Cos7 and MVD7 cells we sought to investigate the normal role of this
protein in the formation and maintenance of these structures. RNA analysis and
immunohistochemistry indicate that LPR1 expression is high in epithelial tissues and cell
lines (Sigal et al., 2005). SK-OV-3 cells are a human ovary surface epithelial cell-derived
cell line with a highly motile and invasive phenotype. When propagated in culture, these
cells exhibit many peripheral actin rich membrane protrusions. Overexpression of EGFP-
LPR1 in SK-OV-3 cells induced a dramatic labeling of membrane protrusions with similar
structures to that observed in HeLa and Cos7 cells (Data not shown). SK-OV-3 cells were
treated with double stranded synthetic RNAs corresponding to LPR1-specific sequences,
RNAi1 and RNAi2, or with a scrambled double stranded RNA construct (RNAic). When
whole cell proteins were analyzed by SDS PAGE, western blotting and scanning
densitometry using the LPR1 selective antibody, we found that RNAi2 produced a marked
reduction (~60%) in expression levels of LPR1 in these cells (Figure 3.11A). These
transfection experiments used pEGFP as a carrier and a reporter plasmid that allowed us to
identify transfected cells, which were analyzed to quantitate the number of filopodia, (again
defined as actin-rich plasma membrane protrusions <5µm in length) using the procedure
described above for the analysis of filopodia in Cos7 cells. As shown in figure 3.11B and
quantitated in figure 3.11C, there was an approximate 50% decrease in the number of
filopodia in SK-OV-3 cells co-transfected with EGFP and RNAi2 (27.3 filopodia cell-1)
versus EGFP expressing cells (56.7 filopodia cell-1) or cells co-transfected with RNAic and
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EGFP (57.5 filopodia cell-1). These findings suggest that normal expression levels of LPR1
are required for maintenance of filopodia in SK-OV-3 cells.
Figure 3.11 LPR1 is Required for Maintenance of Membrane Protrusions in Ovarian Epithelial Cancer
Cells.
A. Proteins from SK-OV-3 cells that were either untransfected (control), or transfected with pEGFP alone or in
combination with the control double stranded RNA (RNAic) or two double stranded siRNAs (RNAi1 and
RNAi2) designed to target LPR1 were analyzed by western blotting for LPR1 expression. Immunoreactive
species were quantitated by scanning densitometry and pixel densities (normalized to control cells) are shown
below each lane of the gel. B. SK-OV-3 cells were co-transfected with pEGFP in combination with either
RNAic or RNai2, and actin organization was visualized by fluorescence microscopy. Stars denote cells
expressing the EGFP marker. C. SK-OV-3 cells were transfected with EGFP alone or in combination with
either RNAic or RNAi2. Phalloidin stained filopodia were counted only in EGFP expressing cells from the
three different categories, and the averages of each were plotted. Error bars denote standard deviations. The
average number of filopodia per cell in EGFP expressing cells was 56.7 (s.d.= 20.6, n=21). EGFP expressing
cells co-transfected with RNAic had an average of 57.5 filopodia per cell (s.d.=13.5, n=26). While EGFP
expressing cells co-transfected with RNAi2 had an average number of 27.3 filopodia per cell (s.d.=12.3, n=25).
Bars, 20µm.
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Table 3.1 LPR1 does not Hydrolyze Phospholipid Substrates Under Conditions that
Readily Support LPP1 Activity.
LPP1 and LPR1 were expressed in insect cells using baculovirus vectors and initial rates of
substrate hydrolysis determined using purified membranes or detergent extracted membrane
proteins as a source of activity using the indicated substrates and the procedures described in
the text. ND; not determined. The data shown means ± s.d. from triplicate determinations
and are representative of three experiments.
Phosphatase Activity (pmol/min/mg)
Substrates (Mixed Micelles)
LPA PA C1P S1P
Control 0.11 ± 0.03 0.13 ± 0.02 0.10 ± 0.01 0.14 ± 0.03
LPP1 32 ± .1 45 ± 2.6 27 ± 3.0 26 ± 1.1
LPR1 0.10 ± 0.03 0.14 ± 0.04 0.14 ± 0.05 0.16 ± 0.05
Substrates (BSA)
LPA PA C1P S1P
Control 0.02 ± 0.002 0.02 ± 0.002 ND 0.07 ± 0.009
LPP1 2.3 ± 0.2 3.1 ± 0.1 ND 2.1 ± 0.1
LPR1 0.02 ± 0.003 0.03 ± 0.001 ND 0.04 ± 0.002
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4. DISCUSSION
LPR1 is an integral membrane protein that is representative of a class of four proteins
with overall homology to the lipid phosphate phosphatases (LPPs). Members of this class of
proteins are characterized by variant catalytic domain homology sequences in which residues
known to be vital for catalysis in other family members are replaced by non-conservative
substitutions (Sigal et al., 2005). In support of this observation we did not detect lipid
phosphatase activity when LPR1 was expressed and assayed using systems that readily
support activity of other LPP enzymes. Although in most cases their functions are not
known, catalytically inactive variants of a wide variety of enzymes including protein and
lipid phosphatases have been described (Kim et al., 2003; Todd et al., 2002). Our results
suggest that LPR1 is similarly a “non-enzyme” relative of the LPPs.
In contrast to its apparent enzymatic inactivity, overexpression of LPR1 induced
dramatic morphological changes in multiple cell types. Overexpression of LPR1 resulted in
a pronounced labeling of actin rich protrusions in both HeLa and Cos7 cells that, on the basis
of their composition and dynamics, were identified as filopodia. Overexpression of LPR1
produced a significant increase in the number of these protrusions. These structures were
very dynamic, and were observed retracting and extending from the periphery and the dorsal
surface of LPR1 expressing cells. While exogenous expression of a number of actin binding
proteins such as fascin and myosin X has been shown to induce formation of filopodia
(Sousa and Cheney, 2005; Svitkina et al., 2003), LPR1, to our knowledge, is a rare example
of an integral membrane protein that induces the formation of these structures.
To further characterize filopodia produced by expression of LPR1, we compared the
appearance and composition of LPR1-induced filopodia to those provoked by overexpression
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of activated cdc42. Filopodia induced by overexpression of LPR1 or activated cdc42 both
necessarily contain a bundled actin core. Actin is essential for extension of filopodia, and
actin polymerization provides the protrusive force that protrudes the plasma membrane
allowing for the growth of filopodia. Bundling of actin filaments is necessary to provide the
mechanical strength required for an extending filopodium to expand the plasma membrane
(Svitkina et al., 2003; Vignjevic et al., 2003). Both actin and the actin bundling protein
fascin were clearly detected along the shaft of filopodia in cells expressing LPR1.
Unconventional myosins, specifically myosin X, have been shown to move along the
filaments within the extending filopodium and to localize at the filopodial tip (Sousa and
Cheney, 2005). Similarly, myosin X was localized to the tips of LPR1-induced filopodia,
however its function within these structures remains to be determined.
In contrast to filopodia observed in cells expressing activated cdc42, LPR1-induced
filopodia were more persistent, longer, thinner, more motile, and projected from both the cell
periphery and dorsal surface. In agreement with our observations that LPR1-induced
filopodia differ from filopodia induced by activated cdc42, we found that a dominant
negative-acting allele of cdc42 had no inhibitory effect on the ability of cells expressing
LPR1 to form filopodia. This conclusion was further supported by our observations that
expression of WASP CRIB domain that sequesters endogenous cdc42 (Nobes and Hall,
1999), also does not interfere with the formation of filopodia in LPR1 expressing cells.
Furthermore, expression of an Arp2/3 binding domain of the WASP homolog SCAR, (SCAR
WA domain) that sequesters and interferes with the functions of endogenous Arp2/3 complex
(Machesky and Insall, 1998), also had not effect on the formation of filopodia in cells
overexpressing LPR1. Taken together, these findings suggest that the mechanism by
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which overexpression of LPR1 induces the formation of filopodia is not dependent on the
canonical Cdc42-WASP-ARP2/3 pathway of filopodial protrusion.
A recent review article highlighted two distinct types of filopodia with unique
morphological appearances (Passey et al., 2004). As reported by many investigators, these
authors noted that transient expression of constitutively active alleles of cdc42 resulted in
cells having a “starfish” phenotype, with short and thick filopodia extending predominantly
from the cell periphery. By contrast, expression of activated alleles of another small GTPase,
Rif, resulted in a cellular phenotype the authors termed “hedgehog”, characterized by the
presence of many long, and thin filopodia that most prominently extend from the dorsal
surface of the cell. Although more work is clearly needed to compare, characterize and
determine the relationship between filopodia characteristic of the “starfish” and “hedgehog”
phenotypes, our observations suggest that LPR1-induced filopodia are more similar to
filopodia induced by activated Rif than by activated cdc42. Focal adhesion proteins and
integrins that are abundant at the tips of cdc42 mediated filopodia (Nobes and Hall, 1995),
play a role in attaching these protrusions to the substratum limiting their localization to the
periphery of the cell, producing the apparent “starfish” appearance. These focal adhesion
proteins are not found at the tips of Rif dependent filopodia (Ellis and Mellor, 2000) and we
could not detect one such protein, paxillin, at the tips of LPR1- labeled filopodia, although it
was readily detected at the base of these structures. The motility of filopodia lacking focal
adhesion proteins at their tips is unrestricted by their association with the substratum which,
in part, likely results in the “hedgehog” phenotype characteristic of cells displaying Rif- and
LPR1-induced filopodia. Despite the similarities between LPR1- and Rif-induced filopodia,
co-expression with dominant negative Rif did not interfere with the ability of LPR1 to
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generate filopodia. This finding implies that the induction of filopodia by LPR1 does not
involve activation of Rif but does not exclude the possibility that Rif and LPR1 share
common effector pathways to regulate the formation of long and thin filopodia at the cellular
dorsal and peripheral surfaces.
Our studies also provide some insight into the likely mechanism underlying the
induction of filopodia in LPR1-expressing cells. The “convergent-elongation” model of
filopodia formation proposes that a filopodium is assembled from the filaments of the
dendritic actin network that are bundled together and elongated to form a nascent filopodium
(Svitkina et al., 2003; Vignjevic et al., 2003). The length of the filopodium is dependent on
the equilibrium between capping proteins that prevent actin polymerization, and anti-capping
proteins such as Vasp and Ena that displace capping proteins from the filament tips, allowing
for the growth of the filopodium (Bear et al., 2002; Lebrand et al., 2004; Svitkina et al.,
2003). Recently published work challenges the ubiquity of this model (Schirenbeck et al.,
2006; Snapper et al., 2001; Steffen et al., 2006). Consistent with these new findings, our
experiments also suggest that LPR1 induces filopodia by an alternate mechanism. The most
intriguing evidence is the ability of LPR1 to generate filopodia in the absence of Vasp or
other members of its family, and the lack of these proteins at the tips of LPR1 filopodia.
Overexpression of myosin X has similarly been reported to induce the formation of dorsal
filopodia in MVD7 cells, which, as we have shown is the case for LPR1, must involve a
mechanism that is independent of Ena/Vasp proteins (Bohil et al., 2006). Although the
authors do not specify the mechanism by which myosin X forms filopodia, these and our
results clearly demonstrate that Vasp is not an essential component of all filopodial tip
complexes.
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The observations reported here raise two major questions about the mechanism by
which LPR1 regulates the formation of filopodia: “Which protein(s) is responsible for actin
nucleation? How are capping proteins prevented from binding to the filopodial tip?” One
possibility may involve both the nucleating and the anti-capping functions of formins, in
particularly mDia2 (Higgs, 2005; Nicholson-Dykstra et al., 2005). Because a suitable
antibody for visualization of mDia2 or its human orthologue in indirect immunofluorescence
studies is not available, we have been unable to determine if endogenously expressed mDia2
is present at the tips of LPR1-induced filopodia. In preliminary studies using overexpression
of tagged variants of mDia2 we observed that that an activated allele, but not the wildtype
form of this formin, is localized primarily to the tips of LPR1 labeled filopodia (Chapter 4
and Figure 4.3). These observations suggest that that LPR1 may influence the localization of
activated formins, but does not activate mDia2 directly.
Although the mechanism by which LPR1 regulates the formation of filopodia
requires further investigation, mutational studies provide insights into possible mechanisms
for regulation of LPR1, and structural determinants within the protein that are important for
the induction of filopodia. Firstly, we found that LPR1 mutants in which amino acids known
to be important for substrate recognition in enzymatically active LPT family members were
replaced with non-conservative substitutions failed to induce the formation of filopodia.
These LPR1 mutants displayed a predominantly intracellular localization and failed to induce
or localize to filopodia at the plasma membrane. Although we do not know the basis for their
altered subcellular localization, these results imply that plasma membrane localization is
required for the induction of filopodia by LPR1. Our finding that residues with proven roles
in substrate recognition in enzymatically active LPTs are important for LPR1 trafficking and
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induction of filopodia, suggests that association of LPR1 with an as yet unidentified lipid
may regulate these processes. Secondly, we identified a critical role for the C-terminus of
LPR1 in the induction of filopodia. The EGFP-LPR1 C-term 43 mutant lacking the C-
terminal 43 amino acids localized to the plasma membrane but failed to induce the formation
of new peripheral filopodia. This finding suggests a critical role for the cytoplasmic C-
terminus of LPR in the induction of filopodia, and the identification of binding partners that
interact with this region of the protein would be a worthwhile strategy for further
investigations of the mechanism by which LPR1 induces the formation of filopodia.
To augment our overexpression studies, RNA interference was used to explore the
role of endogenously expressed LPR1 in the formation and maintenance of filopodia in SK-
OV-3 ovarian cancer cells, which in comparison to other cells and tissues, express the protein
at relatively high levels. Expression of LPR1 (as estimated by western blotting of lysates
from populations of transiently transfected cells) was suppressed to ~60% of control levels
by treatment with an LPR1-selective double stranded RNA and this was accompanied by a
marked decrease in the number of peripheral membrane protrusions. This suggests that, at
least in these cells, LPR1 has a role in maintenance of actin rich structures, such as filopodia.
A recent report has shown that overexpression of LPR3, also termed PRG1, promotes neurite
extension in cultured neuroblastoma cells (Brauer et al., 2003). LPR3 and the other two
members of the LPR family exhibit broad partially overlapping expression patterns (Sigal et
al., 2005), so it plausible that the morphological effect of down regulation of LPR1 on this
and other cell lines may be limited as a result of functional redundancy between LPR family
members.
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In conclusion, LPR1 is an integral membrane protein that localizes to the plasma
membrane and is heavily enriched along the filopodia. Overexpression of LPR1 promotes
the extension of filopodia by a mechanism that is independent of the classic Cdc42-Wasp-
Arp2/3 pathway, does not require Ena/Vasp proteins, and does not involve
dephosphorylation of lipid monophosphate substrates including LPA and S1P. LPR1 is
required for the integrity of actin-rich protrusions in SK-OV-3 ovarian cancer cells. LPR1-
induced structures have a characteristic morphology and a distinct protein composition that
provide further evidence towards its unconventional mechanism of filopodia formation,
which differs from the current “convergent-elongation” model. Further work will be
required to elucidate the mechanism by which LPR1 regulates the formation of filopodia.
5. MATERIALS AND METHODS
Expression constructs- cDNA constructs containing the complete LPR1 ORF were
obtained from Research Genetics/ Invitrogen Inc and sequenced using automated procedures
(GenBank AY304515). These constructs were used for the generation of recombinant
baculovirus vectors using the Fast Bac system (Invitrogen Inc) and for expression of LPR1 in
mammalian cells with either C-terminal HA or EGFP-tags using pcDNA (Invitrogen Inc) or
pEGFP-N1 (Clontech Inc). Site directed mutants of LPR1 were generated using the
quickchange protocol (Stratagene Inc). Insect and mammalian cell vectors for expression of
the LPP enzymes have been described previously (McDermott et al., 2006; Roberts et al.,
1998; Sciorra and Morris, 1999). Vectors for expression of wild type and mutant cdc42 were
provided by Channing Der and Keith Burridge, UNC-Chapel Hill. Wildtype and mutant rif
constructs were provided by Harry Mellor, Bristol-UK.
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Lipid Phosphatase Assays- Previously described methods for expression and assay
of LPPs1-3 were used for investigations of LPR1 (McDermott et al., 2004; Roberts et al.,
1998). Assays contained 100 µM substrate and 3.2 mM Triton X-100 or 10 µM substrate
complexed with fatty acid free BSA at 1 mg/ml. LPP activity was monitored by measuring
phosphate release from [32P]-labeled substrates.
Antibodies and reagents- The anti-LPR1 antibody was raised in rabbits against a
conjugated peptide corresponding to a unique sequence from LPR1, and purified from serum
by affinity chromatography using the immobilized peptide. Other primary antibodies used
were as follows: Chicken anti-GFP polyclonal (Chemicon International); mouse monoclonal
anti-GFP (Covance); mouse monoclonal anti-c-myc antibody (Sigma); mouse monoclonal
anti-fascin (DakoCytomation); mouse monoclonal anti-Ha.11 antibody (Covance); purified
rabbit polyclonal antibody against paxillin provided by Michael Schaller, UNC-Chapel Hill
(Thomas et al., 1999); purified rabbit polyclonal anti-myosin10 antibody provided by
Richard Cheney, UNC-Chapel Hill (Berg et al., 2000); polyclonal rabbit anti-vasp, anti-evl
and anti-mena antibodies provided by James Bear, UNC-Chapel Hill (Bear et al., 2000).
Secondary antibodies used were alexa-fluor 568 goat anti-rabbit IgG, alexa-fluor 568 goat
anti-mouse IgG, fluorescein goat anti-mouse IgG all from Molecular Probes, and FITC
Donkey anti-chicken IgY (Jackson Immunoresearch). Horseradish peroxidase-conjugated
secondary antibodies against rabbit and mouse (Chemicon International) were used for
Western blotting. Rhodamine and 350 alexa fluor-conjugated phalloidin (Molecular Probes)
were used to visualize actin.
Cell transfections and fluorescence microscopy- HeLa and Cos7 cells were grown
on glass coverslips in Dulbecco’s modified Eagle’s medium (DMEM) containing 10% fetal
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bovine serum (Gibco), and, where indicated, transfected using lipofectamine. MVD7 cells
were grown in DMEM supplemented with 15% FBS and transfected using Amaxa
nucleoporation protocol for mouse embryonic fibroblasts. Cells were fixed, permeabilized
and immunostainined using minor modifications of procedures described elsewhere (Sciorra
and Morris, 1999). In brief, cells were fixed in 4% paraformaldehyde, permeabilized with
0.1% Triton X-100 in PBS and incubated with BLOKHEN II blocking reagent (Aves Labs,
Inc.) at a 1:10 dilution in 0.1% Triton X-100 in PBS. Cells were incubated with primary
antibodies overnight in PBS at 4ºC, washed in PBS and secondary antibodies applied at room
temperature for 1 hour. After further washes in PBS samples were mounted in FluoroSave
Reagent (Calbiochem). Images were collected using a Zeiss Axiovert 200 fluorescence
microscope with Plan-Neofluar 63 X objective and either a Zeiss Axio Cam camera or a
Hamamatsu Photonics Orca ER CCD camera. Images were processed using Zeiss Axiovision
software or Metamorph software (Universal Imaging) and figures assembled using Adobe
Photoshop and Adobe Illustrator. Confocal images were collected using an Olympus FV500
Confocal Laser Scanning Microscope. A series of images was taken at 0.2 µm intervals
through the Z plane of the cell and were processed to form a projected image.
Live cell imaging- Cells were imaged using an Orca II CCD camera (Hamamatsu)
with Metamorph software (Universal Imaging) to control illumination shutters and camera
exposure. Timelapse images were obtained by sequential epifluorescent and phase
illumination with a 63X phase 3 lens (Zeiss, Thornwood, NJ). Time-lapse intervals were 5
seconds and exposure times were 100–300 milliseconds, depending on the time-lapse interval
and level of fluorescence. Cells were imaged over periods of 0-60 minutes in HEPES-
buffered Opti-Mem with 5% serum at 37°C. The images were edited and movies generated
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using ImageJ software (Wayne Rasband, NIMH,) and converted to Quicktime files using
Quicktime Pro. Three dimensional confocal microscopy was preformed using an Olympus
FV500 Confocal Laser Scanning Microscope in HEPES-buffered Opti-Mem with 5% serum
at 37°C. A series of images was taken at a single time point at .2 µm intervals through the Z
plane of the cell and were processed to form a projected image.
RNA interference- We used minor adaptations of a previously published procedure
(McManus and Sharp, 2002). In brief, SK-OV-3 cells were plated in 6-well plates at 2.5 x
105 cells/well in McCoy’s media supplemented with 10% FBS and allowed to grow
overnight. Cells were transfected with 1 µg RNA and 1 µg pEGFP in 1 ml of serum free
McCoy’s media. After 4 hours a further 1 ml of McCoy’s media supplemented with 20%
FBS was added to each well. Cells were allowed to grow for 48 hours at 370C before they
were processed for fluorescence microscopy or western blot analysis. RNAs were from
Dharmacon Inc, Lafayette CO and RNA duplexes were prepared according to the
manufacturer's instructions. The RNA sequences used were (sense strands) RNAi 1: CAC
UCA ACG AAG UUA UUC C; RNAi 2- CUU CGA AGG AUC AUA AGA U; RNAi
RNAic- ACU CUA UCU GCA CGC UGA C.
Western blot analysis- Protein concentration was determined by BCA protein assay
(Pierce) using BSA as a standard. Samples were separated on a 12.5% SDS–PAGE or 4-
10% gradient SDS-PAGE, and the proteins were transferred to a PVDF membrane
(Amersham Biosciences). The membrane was incubated with primary antibody, followed by
horseradish peroxidase-conjugated secondary antibody. The immunoreactive bands were
detected with SuperSignal West Pico chemiluminescent substrate (Pierce).
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Other Procedures- Calculations of filopodia in Cos7 and SK-OV-3 cells were done
as discussed in the legend to Figure 3.2. Calculations of LPR1 induced filopodia in the
presence of DN Rif and Cdc42 mutants were performed as discussed in Figure 3.7. Plots
were constructed using Excel. In cases where representative data are shown experiments
have been repeated a minimum of three times with comparable results.
6. LINK TO SUPPLEMENTARY VIDEOS
Quicktime files of videos from which the images shown in figure 3.4 are derived:
Supplementary video 3.4A.mov: HeLa cells expressing EGFP-LPR1, fluorescence and phase
Supplementary video 3.4B.mov: HeLa cells expressing EGFP-LPR1, fluorescence and phase
Frames were captured every 5 seconds; the video frame rate is 10 frames/second.
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CHAPTER 4
NOVEL MECHANISM OF FILOPODIA FORMATION BY
LIPID PHOSPHATASE RELATED PROTEIN 1:
PRELIMINARY RESULTS AND FUTURE DIRECTIONS
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1. ABSTRACT
Lipid phosphatases/phosphotransferases (LPTs) are integral membrane proteins with
diverse biological functions. The most well characterized cellular functions of LPTs are
attributed to their enzymatic activities. Lipid phosphate phosphatases (LPPs), sphingosine
phosphate phosphatases (SPPs) and sphingomyelin synthases (SMS) biochemically
manipulate a variety of phospholipid substrates, which influences intracellular lipid
homeostasis and mediates extracellular lipid signaling through specific phospholipid
receptors. We have also observed that a recently identified, catalytically inactive, member of
the LPT family, lipid phosphatase related (LPR) protein 1, regulates formation of actin-rich
cellular protrusions termed filopodia. The molecular nature of these protrusions is analyzed
in great deal in the previous chapter, and several possible mechanisms, including the
canonical “convergent elongation” model, have been examined and discarded as possible
methods of LPR1 mediated filopodia formation. In this chapter we will analyze another
possible strategy for filopodia initiation by LPR1, which involves selective association of
LPR1 with the plasma membrane through specific interactions with as yet unidentified
phospholipids, and recruitment of a formin, mDia2, that nucleates actin and promotes
filopodial extension. Evidence in support of this model will be examined, and an
experimental strategy testing the validity of this theory will be described.
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2. INTRODUCTION
LPTs exhibit complex biological functions, ranging from simple “housekeeping”
tasks by maintaining a constant pool of intracellular lipids (Yue et al., 2004), to negative
regulators of lipid signaling at the plasma membrane (Brindley et al., 2002), to an unexpected
role in regulation of filopodia formation (Sigal et al., 2007). The latter of these functions is
independent of the phosphatase activity of these proteins. In fact, LPRs, four novel members
of the LPT family, have a variant catalytic domain that is identified by non-conserved
substitutions of crucial residues reported to be vital for the catalysis of both phosphatase and
phosphotransferase reactions in remaining members of the LPT family (Brindley, 2004; Sigal
et al., 2005; Sigal et al., 2007). In agreement with these observations, LPR1 and LPR3 were
unable to support any lipid phosphatase, or phosphotransferase activities, when tested under
the conditions that readily support the activity of other LPT family members (McDermott et
al., 2004; Sigal et al., 2005; Sigal et al., 2007). Despite its enzymatic inactivity, LPR1 can
regulate the formation of dynamic filopodia (Sigal et al., 2007), which were examined in
great detail in the previous chapter.
The ability of LPTs to regulate cellular functions independent of their enzymatic
activity is further exemplified in studies conducted on LPP3, a bonafide and well
characterized lipid phosphatase. Inactivation of murine LPP3, which results in embryonic
lethality, has also demonstrated that LPP3 may negatively regulate Wnt signaling (Escalante-
Alcalde et al., 2003). Embryos from LPP3 null mice show a defect in embryo patterning,
which closely resembles the duplication of axis symmetry observed in embryos from mice
where Wnt signaling was ectopically activated (Popperl et al., 1997; Zeng et al., 1997). In
fact, cells derived from LPP3 null embryos show an increase in Wnt signaling, measured by
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an increase in -Catenin mediated TCF transcription. Rescue with wildtype LPP3 inhibits
Wnt signaling, while expression of a catalytically inactive mutant of LPP3 only partially
reduces -Catenin mediated TCF transcription (Escalante-Alcalde et al., 2003), suggesting
that this process is in part independent of the ability of LPP3 to catalyze a phosphatase
reaction. An independent assay, which examined markers that were upregulated during
capillary morphogenesis of endothelial cells in response to VEGF, identified human LPP3 as
a protein that regulates cell/cell interaction and cell spreading through the association of its
RGD (Arg, Gly, Asp) sequence with v3 and 51 integrins, and an overall increase in p120-
catenin expression (Humtsoe et al., 2003).
In light of our discovery that expression of LPR1 dramatically reorganizes the actin
cytoskeleton (Sigal et al., 2007), the observations that LPPs may regulate the activities of
both p120- and -Catenins serve as an attractive finding, especially given the ability of
catenins to interact with cellular pools of filamentous actin (F-actin) (Anastasiadis and
Reynolds, 2000). However, LPR1 does not contain an RGD motif, which is a sequence
specific only to the human LPP3 protein. Furthermore, to my knowledge, there is no
evidence that Wnt signaling directly regulates filopodia formation, although the ability of
cells with abnormal Wnt signaling activity to extend filopodia is indirectly affected, due to an
overall defect in cellular migration (De Calisto et al., 2005; Nishita et al., 2006). Most
importantly ectopic expression of LPP3 does not reorganize the actin cytoskeleton (Sciorra
and Morris, 1999; Sigal et al., 2007), while LPR1-mediated extension of actin-rich filopodia
is an immediate phenotype, limited only by the rate of protein expression following
transfection. This suggests that LPR1 employs a novel mechanism of filopodia formation
unrelated to the ability of a homologous protein, LPP3, to regulate catenin signaling.
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Furthermore, as analyzed in the previous chapter, the ability of LPR1 to extend filopodia is
not mediated by the canonical convergent-elongation model of filopodia formation.
Examination of actin organization within intact filopodia of Dictyostelium discoideum
by cryo-electron tomography provides insight into an alternative mechanism of filopodia
organization. The ‘‘sequential nucleation model” illustrates that the actin network within
Dictyostelium filopodia is composed of multiple, intermittent, short (~200nm) actin filaments
rather then a continuous actin backbone (Medalia et al., 2007). An independent study
demonstrates that filopodial protrusion is best achieved by actin filaments shorter than
500nm in length (Berro et al., 2007). These exert the significant force needed to extend the
plasma membrane, and the magnitude of this force decreases radically with increasing
filament length, resulting in filament buckling rather then filopodial extension. This
observation supports the proposed model that filopodia are composed of multiple short actin
filaments. These filaments orient themselves parallel to the filopodium axis in the shaft of
the filopodium, but are slightly oblique at the filopodium tip. This organization provides a
greater surface area for plasma membrane contact that allows for filopodia extension
(Medalia et al., 2007). The authors further note that these short filaments can be quickly
reoriented in the filopodium to accompany filopodial elongation or bending. To
accommodate these rapid filopodial dynamics, actin has to be quickly polymerized and
nucleated de novo. Given that actin polymerization by Arp2/3 produces only a continuous,
highly branched actin network, the other likely candidate for actin nucleation and
polymerization resulting in straight actin filaments is a formin, specifically dDia2 that is
present at the tips of Dictyostelium filopodia (Schirenbeck et al., 2005). Given that these
filaments undergo rapid reorganization and nucleation, filopodia may occasionally become
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branched at a point where the number of actin filaments doubled. These is a common
phenotype of Dictyostelium filopodia (Medalia et al., 2007), and is occasionally observed
with LPR1 labeled filopodia (Figure 3.2B). In light of this similarity, and based on our
previous observations that LPR1 extends filopodia in a cdc42 and arp2/3 independent
pathway, we suggest that LPR1 involves the nucleating activity of formins to extend
filopodia. Based on studies using pharmacological inhibitors of actin motility, in
combination with an immunofluorescence approach, we propose and analyze a model of
LPR1 regulation of filopodia formation through recruitment of mDia2 to the plasma
membrane. Preliminary data in support of this mechanism will be examined, and additional
experiments will be proposed testing the validity of this model.
3. RESULTS AND DISCUSSION
Cytochalasin D treatment dramatically attenuates the motility of LPR1 labeled
filopodia- The convergent elongation model of filopodia formation is dependent on a
number of crucial proteins that are essential for the integrity of this model (Svitkina et al.,
2003; Welch and Mullins, 2002). Recent evidence has questioned the ubiquitousness of this
hypothesis (Schirenbeck et al., 2006; Snapper et al., 2001; Steffen et al., 2006). Similarly,
we demonstrated that LPR1 induces filopodia formation in the absence of molecules such as
cdc42, arp2/3 and Vasp, suggesting that LPR1 employs an alternate method of filopodia
regulation. To experimentally distinguish these two models, we wished to examine the
response of LPR1- and cdc42- induced filopodia to treatment with cytochalasin D (CD), a
fungal metabolite that binds the barbed end of actin filaments, thus preventing actin
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Figure 4.1 Cytochalasin D does not Inhibit Filopodia Motility in Cdc42 Expressing
Cells. Cos7 cells expressing EGFP-Cdc42 Q61L were imaged by time lapse microscopy in
the absence (A) or presence (B) of 1µM cytochalasin D to examine the dynamics of EGFP
labeled filopodia. Panels show selected individual images. Arrows indicate filopodia that
display dynamic characteristics when compared to the previous panel. EGFP-Cdc42 Q61L
constructs display predominantly intracellular localization, therefore these panels exhibit
higher magnification images of the periphery of the cells to focus exclusively on filopodia.
Bars, 10µm. The panels are individual frames chosen from supplementary videos 4.1A and
4.1B.
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polymerization (Brenner and Korn, 1979). Cos7 cells expressing either cdc42 Q61L or
LPR1 were imaged by time lapse microscopy in the absence and presence of low levels of
CD (1µM). Cells expressing GFP-Cdc42 Q61L protrude dynamic filopodia (Figure 4.1A and
supplementary video 4.1A), the motility of which was not attenuated in the presence of CD,
even when imaged 45 minutes post CD treatment (Figure 4.1B and supplementary video
4.1B). LPR1 expressing cells extend very dynamic filopodia in the absence of CD (Figure
4.2A), however their motility was significantly attenuated immediately upon challenge with
1µM CD (Figure 4.2B). Furthermore, the majority of LPR1-filopodia in CD treated cells
underwent progressive and rapid retraction, resulting in a near complete loss of all motile
filopodial protrusions. Compatible results were achieved in Cos7 cells expressing EGFP-
LPR1 treated with 100nM CD (Figure 4.2C), although lower levels of CD had a more
gradual effect on attenuating the dynamics of these protrusions, some of which remained
motile for up to 10-20 minutes post treatment. (Images in Figure 4.2 are selected from
corresponding supplementary videos 4.2A, 4.2B and 4.2C.)
The results outlined above confirm our previous data that LPR1 and cdc42 regulate
formation of filopodia by distinct mechanisms, as the two types of filopodia respond very
differently to treatment with CD. This marked difference may be explained by two related
hypotheses. Given the presence of Vasp at the tips of cdc42-filopodia (Figure 3.9), we can
speculate that Vasp protects the barbed ends of these protrusions against CD, and the lack of
Vasp at the tip complex of LPR1-filopodia (Figures 3.8 and 3.10) may account for the
dramatic and rapid response to CD treatment. However, it was shown that 100 nM
concentration of CD is enough to displace Mena from the tips of filopodia in NG108
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Figure 4.2 Cytochalasin D Inhibits Filopodia Motility in LPR1 Expressing Cells. Cos7
cells were transfected with EGFP-LPR1 vector. The cells were imaged by time lapse
microscopy, and panels corresponding to individual images are shown. A. Cells were
imaged in the absence of cytochalasin D. Arrows indicate filopodia that display dynamic
characteristics when compared to the previous panel. B. Cells were treated with 1µM
cytochalasin D prior to imaging. Arrows in each panel display filopodia that lost their
dynamic characteristics following drug administration, and either remained motionless
throughout the course of imaging or undergone progressive retraction. C. Cells were treated
with 100nM cytochalasin D prior to imaging. Arrows represent protrusions that retained
their motility in the early time frames, but lost all movement in the later stages of imaging.
Bars, 10µm. Images are picked from supplementary videos 4.2A, 4.2B and 4.2C.
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nueroblastoma growth cones, without affecting filopodia per se (Bear et al., 2002). These
findings suggest that an alternate explanation may exist for the observed difference in
filopodial response to CD. The insensitivity of cdc42-filopodial dynamics to CD may be
attributed to their protection against actin depolymerization at the pointed end due to the
presence of the Arp2/3 complex (Svitkina and Borisy, 1999; Svitkina et al., 2003). Although
CD does not depolymerize actin filaments directly, it prevents actin polymerization at the
barbed end, resulting in conditions favoring actin depolymerization from the opposite pole.
The presence of an actin binding complex, such as Arp2/3, may stabilize the actin filament
and decrease the rate of actin turnover. LPR1 extends filopodia in an Arp2/3 independent
manner (Sigal et al., 2007) suggesting that this complex may be excluded from the base of
LPR1-labeled filopodia, thereby leaving these protrusions vulnerable to rapid actin
depolymerization from the pointed end. In support of this concept, CD treated LPR1-
expressing cells exhibited rapid lose of filopodia, probably due to actin depolymerization,
although the rate of filopodial retraction was not directly compared to the rate of actin turn
over in these cells. Furthermore, as discussed in the introduction of this chapter, the actin
network of LPR1 filopodia, similar to Dictyostelium filopodia, may be assembled from short
discontinuous filaments. These would be much more vulnerable to CD treatment than a
continuous actin backbone characteristic of cdc42 filopodia generated by Arp2/3
polymerization (Svitkina et al., 2003).
Activated mDia2 localizes to the tips of LPR1 labeled filopodia- A study
examining actin based motility of the barbed end actin associated formin, mDia1, reveals a
striking similarity in its response to the treatment with 1µM CD (Higashida et al., 2004) with
that of LPR1-filopodia. CD drastically and suddenly inhibits all mDia1 actin associated
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motility 10 seconds following drug administration, in a manner similar to how CD inhibits
LPR1-filopodial motility. This observation suggests that LPR1 regulates filopodia formation
in a formin dependent manner. This correlates with our previous data showing that LPR1
filopodia are formed independent of Vasp and the Arp2/3 complex, suggesting that the anti-
capping and polymerizing activity of these proteins may be replaced by the nucleating and
the anti-capping functions of formins (Faix and Rottner, 2006). The formin suggested to be
involved in filopodia formation is mDia2 (Pellegrin and Mellor, 2005). An obvious question
arises whether endogenous mDia2 localizes to the tips of LPR1 filopodia. Analyses of this
issue however, is limited by the lack of commercially available functional antibodies against
mDia2. Immunofluorescence microscopy was therefore used to analyze the localization of
co-expressed proteins.
Co-expression of HA-LPR1 and wildtype mDia2 resulted in two distinct localization
patterns for both proteins: LPR1 was uniformly distributed along the filopodial shafts, while
mDia2 had a distinct intracellular localization that was identical to its localization when
solitary mDia2 was expressed in Cos7 cells (Figure 4.3A,B). This particular cell line was
chosen due to its lack of any detectable amounts of endogenous Rif (Mellor- personal
communication), a physiological activator of Dia2 (Pellegrin and Mellor, 2005). This
experimental model, therefore, limits the ability of ectopically expressed mDia2 to be
activated by endogenous mechanisms. When HA-LPR1 was co-expressed with an activated
allele of mDia2 (RBD mDia2), localization of the formin became concentrated at the tips of
filopodia labeled by LPR1 (Figure 4.3C). This staining was unlike that of RBD mDia2
when expressed on its own, which predominantly labeled stress fibers, cortical actin and few
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Figure 4.3 Activated, but not Full-length mDia2 is Localized to the Tips of LPR1-
filopodia.
A. Cos7 cells were transfected with plasmids expressing either YFP-mDia2 or YFP-RBD
mDia2. Localization of YFP tagged proteins, as well as actin organization were analyzed by
immunofluorescence microscopy. Cos7 cells were transfected with vectors for expression of
HA tagged LPR1 and that of either YFP-mDia2 (B) or YFP-RBD mDia2 (C). Cells were
analyzed by fluorescence microscopy to determine and compare the distribution of HA and
EGFP tagged proteins. Bars, 10µm.
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peripheral filopodia (Figure 4.3A). This data suggests that LPR1 cannot directly activate
mDia2, but may have the ability to regulate its localization once mDia2 is activated and
relieved of its autoinhibited conformation.
LPR1 may selectively target mDia2 to the site of filopodia formation- Although
numerous studies describe the role of formins in maintenance of the actin network, very few
reports deal with the mechanisms by which formins are localized to their target areas. It has
been proposed that mDia2 may be a target for multiple Rho GTPases, such as Cdc42, Rif and
even RhoA (Higgs, 2005; Pellegrin and Mellor, 2005). Given the differences in cellular
morphologies exhibited by expression of these GTPases, there needs to be a mechanism that
governs the selection of an appropriate GTPase effector, and a mechanism for properly
targeting this effector to the specific cellular localization to exhibit the desired effect of
GTPase expression. Mutational analyses of LPR1, analyzed in the previous chapter, show
that residues with proven roles in substrate recognition in enzymatically active LPTs are
important for LPR1 trafficking and induction of filopodia. These data suggest that LPR1
may selectively associate with regions of the plasma membrane due to interaction of LPR1
with as yet an unidentified lipid. Based on these, and previous observations a working model
of LPR1 regulated filopodia formation is proposed (Figure 4.4). LPR1 is targeted to the
plasma membrane due to specific interactions with lipid phosphates. In an independent step,
mDia2, or related formin is activated by its association with a Rho GTPase, such as Rif.
Once the formin is activated it is recruited to the plasma membrane due to its probable
interaction with the C-terminus of LPR1. We previously demonstrated that deletion of the
last 43 residues of LPR1 abolishes formation of new filopodia but does not interfere with the
trafficking of this protein, suggesting that the integrity of these 43 residues is required for
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LPR1 to form new cellular protrusions (Sigal et al., 2007). Once a formin is properly
recruited, it drives actin polymerization and promotes the formation of new filopodia.
Figure 4.4 Model of LPR1 Regulated Filopodia Formation.
This model is speculative, based in part on preliminary overexpression studies, and needs to
be substantiated by further experiments.
(1) LPR1 is localized to the plasma membrane via its interaction with membrane-specific
phospholipids. (2) Concurrently, mDia2 is activated by a Rho GTPases, such as Rif. (3)
Activated mDia2 is recruited by LPR1 to the plasma membrane via the formin’s interaction
with the LPR1 C-terminus tail. (4) Formin dependent actin polymerization drives filopodia
protrusions.
143
4. EXPERIMENTAL STRATEGIES
Interaction between LPR1 and mDia2 may be validated by an
immunoprecipitation and immunofluorescent techniques- The proposed model of LPR1-
mediated filopodia formation (Figure 4.4) suggests an association between the C-terminus of
LPR1 with an activated mDia2 molecule. To verify this interaction, an immunoprecipitation
(IP) approach may be used. Cos7 cells will be co-transfected with either EGFP-LPR1,
EGFP-LPR1 C-term 43 or EGFP-LPR1 S198T mutant in combination with either myc
tagged wildtype mDia2 or RBD mDia2. Cell lysates will be generated, and relevant
complexes consequently immunoprecipitated using either a GFP or myc specific antibody
and blotted with the reverse antibody to detect whether the two proteins may be pulled down
in the same complex.
Our model predicts an interaction between EGFP-LPR1 and RBD mDia2, and
possibly a similar interaction between EGFP-LPR1 S198T and the activated formin.
Although this LPR1 mutant does not localize to the plasma membrane and does not induce
the formation of filopodia, it contains an intact C-terminal tail that we suggest is important
for LPR’s association with mDia2. In fact this mutant, if found to IP with RBD mDia2,
may be able to sequester activated mDia2 intracellularly, which could be examined
experimentally by immunofluorescence. Myc tagged RBD mDia2 localizes to, and forms
prominent stress fibers and a very well defined cortical actin (Figure 4.3A). Sequestration of
this activated formin by co-expression of EGFP-LPR1 S198T should, therefore, result in a
visible co-localization between the two proteins, and a redistribution of cellular F-actin.
A functional antibody against LPR1 has been generated (Sigal et al., 2007), however,
presently no such means of detecting endogenous mDia2 exist. Therefore, examining
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whether endogenous LPR1 and Dia2 could be IP’d together is beyond our present capacity.
However, the results of our IP overexpression experiment may be validated by determining
whether endogenous LPR1 may pull down exogenously expressed mDia2. Cos7 cell lysates
expressing either myc tagged wildtype mDia2 or RBD mDia2 may be immunopercipitated
with an LPR1 selective antibody, and blotted against a myc tagged protein. If the results
confirm an interaction only between RBD mDia2 and LPR1, a follow up experiment could
be performed to determine whether LPR1 associates with the wildtype formin in the presence
of a Rho GTPase. Lysates from cells co-transfected with wildtype mDia2 and one of the
three activated Rho GTPases, such as Rif Q75L, Cdc42 Q61L and Rho Q63L, will be IP’d
with an LPR1 specific antibody, and examined by western blotting. The experiment would
analyze whether LPR1 has the ability to associate with mDia2 following its activation, and
would examine whether this interaction is regulated by a presence of a particular Rho
GTPase.
A GST C-terminal peptide may be used to identify binding partners of LPR1,
and may further be used to interfere with the ability of LPR1 to extend filopodia-
Given the significance of the last 43 residues of LPR1 for its ability to form filopodia, a
glutathione S-transferase (GST) pull down assay may be used to examine the interactions of
this domain. A GST tagged peptide corresponding to the C-terminal 43 residues of LPR1
will be generated, purified, and mixed with cell lysates. The GST fused peptide will be
collected by application of glutathione sepharose beads. The collected sample will be
separated by gel electrophoresis, and analyzed by mass spectrometry for binding partners
against a negative control from a pull down assay with an empty GST construct. If our
expectations are correct, we expect to detect associations of the C-terminal LPR1 tail with
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mDia2 and possibly Rif. However, new and unexpected interactions may arise from this
assay, and will need to be further validated by immunoprecipitation and immunofluorescence
approaches.
The GST-C terminal tail of LPR1, if confirmed to interact with actin nucleating
machinery responsible for filopodia formation, may also be used as means of inhibiting the
activity of wildtype LPR1. The GST tag may be cleaved by proteolysis, and the resulting
peptide can be injected into cells expressing EGFP-LPR1. The microinjected C-terminal
peptide (CTP) should compete with EGFP-LPR1 for the same effector proteins, and therefore
interfere with the ability of wildtype LPR1 to extend filopodia. This phenotype will be easily
detected by fluorescence microscopy, and may be analyzed quantitatively by counting LPR1
labeled filopodia in populations of EGFP-LPR1 expressing cells in the presence or absence
of the microinjected peptide. Successful attenuation of LPR1-mediated filopodia formation
by CTP will offer another tool to analyze the mechanism of regulation of filopodia formation
by LPR1.
RNAi and interfering peptides may be used to examine whether LPR1 is
required for Rif to extend filopodia- Previously, we examined whether Rif regulates
LPR1’s ability to form filopodia. Despite the similarities between filopodia induced by the
two proteins, we demonstrated that filopodia formation by LPR1 was not attenuated by the
dominant negative Rif. Our current model for LPR1-mediated filopodia initiation (Figure
4.4) suggests that LPR1’s ability to interact with, and regulate the localization of mDia2 may
indirectly govern the ability of Rif to potentiate filopodia formation. Rif overexpression is
reported to induce filopodia formation by activation of mDia2. Sequestration of endogenous
mDia2 by CTP should therefore interfere with the ability of Rif to induce filopodia. Cells
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ectopically expressing Rif Q75L, microinjected with CTP, should have fewer filopodia then
uninjected control cells if our model holds true. Rnai approach may also be used to
corroborate the above data. An Rnai2 construct that specifically targets LPR1 (Chapter 3)
may be co- transfected with Rif Q75L and examined by immunofluorescence microscopy to
detect formation of filopodia. The number of these filopodia can be quantitated and
compared to the number of filopodia in cells co-transfected with Rif Q75L and a control,
non-specific Rnai construct. This will ascertain whether knock down of LPR1 diminishes the
number of Rif induced filopodia. However, RNAi does not guarantee a complete knock
down of LPR1 in every single cell examined, therefore this approach may yield less
conclusive results, especially since we do not know the stoichiometric relationship between
LPR1 and its effectors. Despite this limitation, the two experiments in combination should
provide an insight into LPR1’s ability to regulate Rif-induced filopodia.
The ability of LPR1 to interact with phospholipids may be examined by
biochemical and fluorescent approaches- Proper trafficking of LPR1 to the plasma
membrane is required for its induction of filopodia (Sigal et al., 2007). Mutational analyses
of potential phospholipid binding sites suggest that LPR1’s plasma membrane association
depends on its association with particular lipid phosphates. Membrane lipid arrays and lipid
strips containing a number of biologically abundant membrane associated lipids (Echelon
Inc.) may be used to detect the interactions between these lipids and recombinant LPR1
proteins. We previously generated recombinant LPR1 and LPR1 S198T proteins using a
baculovirus expression system (Chapter 3 and data not shown). These contain a His tag that
may be used to column purify these proteins, although the purified product may be
contaminated with remnants of membrane extracts and integral membrane proteins. The
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purified proteins will be incubated with pre-blocked membrane arrays and membrane strips.
Following a number of washes, the membrane strips/arrays will be incubated with an LPR1
specific antibody, followed by an application of horseradish peroxidase-conjugated
secondary antibody. Interaction of LPR1 and LPR1 S198T with a number of different lipids
will be detected by chemiluminescence methods. This approach will analyze whether LPR1
can interact with membrane associated lipids; which lipids are preferred; and how do these
interactions differ from the ability of LPR1 S198T to interact with the same membrane lipids.
If a specific interaction between LPR1 and PA is observed, a method adapted
from the study examining ligand specificity of LPA receptors (Wang et al., 2001) may be
used to analyze this interaction in a concentration or time dependent fashion. Recombinant
LPR1, LPR1 S198T, and control proteins such as LPP1, LPA specific receptor (LPA1), and
an S1P specific receptor (S1P1), will be incubated for varying periods of time with a
prepared lipid mixture containing unlabeled LPA or PA, in combination with [32P] labeled
lipid. Similar incubations will be set up with varying concentrations of lipids for a set period
of time. These samples will be washed through GF/B filters. The filters will be washed with
BSA to remove free lipids. And the resulting lipid/protein complexes will be quantitated by
liquid scintillation. The results will examine the binding specificity of LPR1 and the LPR1
mutant to LPA and PA.
The use of fluorescently labeled lipid analogues in the study of LPPs is described in
Chapter 2. The method could be adapted to demonstrate an association of fluorescently
labeled lipids with LPR1-labeled filopodia using fluorescence microscopy. LPPs facilitate an
accumulation of dephosphorylated lipid product intracellularly following exogenous
application of fluorescently labeled phospholipids (Renault et al., 2004; Roberts and Morris,
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2000). Phosphatase inactive LPP variants fail to induce any lipid accumulation. This result
would argue that cells expressing LPR1, an inactive variant of the LPT family, would also
fail to accumulate fluorescently labeled lipids intracellularly. However, exogenously applied
fluorescent lipid analogues may still selectively associate with LPR1 at the plasma
membrane, and may co-localize with LPR1-labeled filopodia after thorough washing with
non-ionic solutions. BODIPY labeled lipids (Avanti) will be chosen based on the results of
the membrane strip/array experiment, and incorporated into vesicles composed of 20:5
PC/BODIPY lipids. These vesicles will be applied to cells expressing Ds-Red LPR1 and
imaged in separate channels to detect localization of LPR1 and lipids. Co-localization would
confirm an interaction between LPR1 and the lipids in question.
5. MATERIALS AND METHODS
Constructs, antibodies and solutions were for the most part described elsewhere
(McDermott et al., 2006; Sigal et al., 2007). YFP-mDia2 and YFP-RBD mDia2 were
provided by Art Alberts, Van Andel Research Institute-Michigan, USA. EGFP-Cdc42 Q61L
construct was provided by Keith Burridge, UNC-Chapel Hill. Cytochalasin D was purchased
from Biomol Int., and prepared according to manufacturers’ instructions.
Cell culture, transfections and fixed cell immunofluorescence microscopy
techniques were described previously in the materials and methods section of Chapter 3.
Cytochalasin D was administered directly into the media at varying concentrations and cells
were imaged by methods described below.
Live cell time lapse microscopy of CD treated cells was performed in HEPES-
buffered Opti-Mem with 5% serum at 37°C using an a Zeiss Axiovert 200 fluorescence
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microscope with Plan-Neofluar 63 X objective and a Hamamatsu Photonics Orca ER CCD
camera. Fluorescence images were captured at varying time-lapse intervals, between 20-60
seconds, and exposure times were varied depending on the time-lapse interval and level of
fluorescence. Cells were imaged for periods of 10-60 minutes, and images were edited using
ImageJ software (Wayne Rasband, NIMH) and Metamorph software (Universal Imaging).
6. CONCLUDING REMARKS
LPT is a complex family of proteins whose members play vital roles in regulation of
cell development (Escalante-Alcalde et al., 2003; Renault et al., 2004), cell signaling
(Brindley, 2004; Brindley et al., 2002; Nanjundan and Possmayer, 2003; Sciorra and Morris,
2002), intracellular lipid regulation (Alderton et al., 2001; Leung et al., 1998; Leung et al.,
1999; Yue et al., 2004) and filopodia formation (Brauer et al., 2003; Savaskan et al., 2004;
Sigal et al., 2007). Given the ability of these proteins to interact with a number of lipid
phosphates, special techniques are required to analyze the biological and biochemical
functions of these proteins. Some of these unique methods are analyzed in great detail here,
and elsewhere (McDermott et al., 2006). Presently, however, most methods rely on in vitro
biochemical assays and physiologically questionable overexpression studies. Knock out and
gene silencing strategies, in combination with model organisms studies may be used
effectively in the future to dissect the biological functions of LPT proteins. Furthermore,
fluorescently labeled substrates may provide an opportunity to investigate the biochemical
activities of these proteins in-vivo. Proper examination and regulation of these lipid
modifying enzymes may prove essential in bio-medical applications, as some of these
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enzymes have been reported to regulate certain pathophysiological conditions such as cancer
and atherosclerosis (Smyth et al., 2003; Tanyi et al., 2003).
LPR1 regulates formation of cellular protrusions called filopodia (Sigal et al., 2007).
Pathophysiological roles for LPR1 have not yet been examined. However, the related
LPR3/PRG1 protein of the LPR subfamily of LPTs, is reported to localize within the
membranes of outgrowing axons. From that location, it facilitates axonal outgrowth during
development and regenerative sprouting (Brauer et al., 2003). This proposes a role for LPR3
in regulation of neuronal plasticity. LPR1, on the other hand, is not primarily restricted to
the brain, and exhibits a wider expression pattern. (Sigal et al., 2005; Sigal et al., 2007).
Furthermore, analysis of EST abundance data reveals a strong expression of LPR1 during
fetal development and in certain types of cancerous cell types and tissues
(http://www.ncbi.nlm.nih.gov/UniGene/ and the cancer genome anatomy project -
http://cgap.nci.nih.gov/ see also Figure 3.11A). Regulation and maintenance of cellular
protrusions, such as filopodia, is suggested to mediate proper cellular migration and
development (Wood and Martin, 2002), while excessive, uncontrolled migration is a
phenotype of metastatic cancerous cells (Roger et al., 2006; Yamaguchi et al., 2005).
Elucidating the mechanism of LPR1 mediated filopodia formation, and developing new tools
and techniques to regulate the biological activity of LPR1 and other LPTs, therefore,
promises to provide novel therapeutic strategies with large medical applications.
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7. LINK TO SUPPLEMENTARY VIDEOS
Quicktime files of videos from which the images shown in figure 4.1 and 4.2 are
derived:
Supplementary video 4.1A.mov: Cos7 cells expressing EGFP-cdc42 Q61L, no CD,
fluorescence. Frames captured every 1 minute
Supplementary video 4.1B.mov: Cos7 cells expressing EGFP-cdc42 Q61L, 1µM CD,
fluorescence. Frames captured every 30 seconds.
Supplementary video 4.2A.mov: Cos7 cells expressing EGFP-LPR1, no CD, fluorescence.
Frames captured every 20 seconds.
Supplementary video 4.2B.mov: Cos7 cells expressing EGFP-LPR1, 1 µM CD, fluorescence.
Frames captured every 1 minute.
Supplementary video 4.2C.mov: Cos7 cells expressing EGFP-LPR1, 100nM CD,
fluorescence. Frames captured every 1 minute.
The video frame rate of all files is 10 frames/second
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